Skip to the page
Get started – free

Data / Research funding / Lung Cancer

Lung Cancer: 1,479 NIH awards ($2B) to 294 organizations

1,479 NIH awards ($2B) in the NIH spending category Lung Cancer, to 294 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Lung CancerWatch Lung Cancer
Topic
NIH spending category

Awards

The 500 largest of 1,479 awards in the window.

AwardAgencyInstitute or divisionFiscal yearAmount in windowStartEndPrincipal investigatorSource
NCI Early Career Cancer Clinical Investigator AwardNIHNational Cancer Institute2021 to 2025$65,560,307March 10, 1997November 30, 2026EBERT, BENJAMIN LEVINEreporter.nih.gov
Cancer Center Support GrantNIHNational Cancer Institute2021 to 2025$39,144,749September 1, 1998August 31, 2027PARK, BEN HOreporter.nih.gov
Cancer Center Support GrantNIHNational Cancer Institute2021 to 2025$29,642,385September 12, 1997November 30, 2025RATHMELL, WENDY KIMRYNreporter.nih.gov
Mayo Clinic Comprehensive Cancer Center Support GrantNIHNational Cancer Institute2021 to 2025$29,249,641April 25, 1997August 31, 2030WILLMAN, CHERYL LYNNreporter.nih.gov
Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM)NIHNational Institute on Minority Health and Health Disparities2021 to 2025$24,809,662September 24, 2021December 31, 2026ALLEN, MICHELE Lreporter.nih.gov
Moffitt Cancer Center Support GrantNIHNational Cancer Institute2021 to 2025$22,007,955February 18, 1998January 31, 2027CLEVELAND, JOHN L.reporter.nih.gov
Center for Research, Health and SocietyNIHNational Institute on Minority Health and Health Disparities2021 to 2025$21,943,481September 24, 2021June 30, 2027CORNELL, CAROL ELLENreporter.nih.gov
UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal CancerNIHNational Cancer Institute2021 to 2025$21,851,455September 1, 2025August 31, 2026SCHULICK, RICHARD Dreporter.nih.gov
Cancer Center Support GrantNIHNational Cancer Institute2021 to 2025$20,980,807December 1, 1996February 28, 2029MAITRA, ANIRBANreporter.nih.gov
West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)NIHNational Institute of General Medical Sciences2021 to 2025$20,261,619September 30, 2001July 31, 2029JOSHI, TRUPTIreporter.nih.gov
The American Lung Association (ALA) Lung Health CohortNIHNational Heart, Lung, and Blood Institute2021 to 2024$17,159,433June 15, 2019June 30, 2026KALHAN, RAVIreporter.nih.gov
The Tisch Cancer Institute - Cancer Center Support GrantNIHNational Cancer Institute2021 to 2025$14,629,412August 1, 2015July 31, 2030PARSONS, RAMON Ereporter.nih.gov
Massey Cancer Center - Cancer Center Support GrantNIHNational Cancer Institute2021 to 2025$13,606,962December 1, 1995April 30, 2028WINN, ROBERT A.reporter.nih.gov
Targeting Lung Cancer VulnerabilitiesNIHNational Cancer Institute2021 to 2024$8,708,604September 5, 1997August 31, 2025MINNA, JOHN D.reporter.nih.gov
LOW-DOSE COMPUTED TOMOGRAPHY IMAGES AND CORRESPONDING DATANIHNational Cancer Institute2022 to 2024$7,205,078September 16, 2022September 15, 2025FERNANDEZ, ANNAreporter.nih.gov
Coordinating center for the NCI small cell lung cancer research consortiumNIHNational Cancer Institute2021 to 2025$7,127,674June 24, 2022May 31, 2027RUDIN, CHARLES M.reporter.nih.gov
Washington University/Siteman Cancer Center Lead Academic SiteNIHNational Cancer Institute2021 to 2025$6,572,668March 5, 2019February 28, 2026BARTLETT, NANCY Lreporter.nih.gov
The Boston Lung Cancer Survival CohortNIHNational Cancer Institute2021 to 2025$6,033,521June 1, 2017May 31, 2028CHRISTIANI, DAVID Creporter.nih.gov
Center for Research to Optimize Precision Lung Cancer Screening in Diverse PopulationsNIHNational Cancer Institute2021 to 2023$6,033,066April 15, 2018July 31, 2025RITZWOLLER, DEBRA Preporter.nih.gov
EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer AssessmentNIHNational Cancer Institute2021 to 2025$6,012,718September 13, 2018August 31, 2028WONG, DAVID Treporter.nih.gov
Decoding And Targeting The LKB1-AMPK Signaling Pathway In CancerNIHNational Cancer Institute2021 to 2025$5,725,440August 1, 2017July 31, 2031SHAW, REUBENreporter.nih.gov
ASPiRE: Advancing Science & Practice in the Retail EnvironmentNIHNational Cancer Institute2021 to 2023$5,479,825September 1, 2018August 31, 2025RIBISL, KURT M.reporter.nih.gov
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer CareNIHNational Cancer Institute2021 to 2025$5,422,908March 5, 2019February 28, 2026BURSTEIN, HAROLD JOHNreporter.nih.gov
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health CenterNIHNational Cancer Institute2021 to 2025$5,355,395September 17, 2018August 31, 2028WILKIE, DIANA Jreporter.nih.gov
Lung Adenocarcinoma: From Genome Alterations to Therapeutic DiscoveryNIHNational Cancer Institute2021 to 2025$5,246,301August 1, 2015July 31, 2028MEYERSON, MATTHEW L.reporter.nih.gov
Novel therapeutic development for small cell lung cancerNIHNational Cancer Institute2021 to 2025$5,214,420August 10, 2021July 31, 2028RUDIN, CHARLES M.reporter.nih.gov
Chromosome Instability Drives Metal-Induced Lung CancerNIHNational Institute of Environmental Health Sciences2021 to 2025$5,203,730August 1, 2021June 30, 2029WISE, JOHN PIERCEreporter.nih.gov
Clinical Utility of a Combined Biomarker Approach to Diagnose Lung CancerNIHNational Cancer Institute2021 to 2025$5,089,144August 16, 2010August 31, 2027GROGAN, ERIC Lreporter.nih.gov
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesisNIHNational Cancer Institute2021 to 2025$4,951,939August 14, 2015July 31, 2029ATTARDI, LAURA Dreporter.nih.gov
Clinical Validation Center for Lung Cancer Early DetectionNIHNational Cancer Institute2022 to 2025$4,880,009September 1, 2022August 31, 2027HANASH, SAMIR Mreporter.nih.gov
Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure and Health OutcomesNIHNational Cancer Institute2021 to 2023$4,874,420December 15, 2017November 30, 2023THORPE, LORNAreporter.nih.gov
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategiesNIHNational Cancer Institute2021 to 2025$4,726,654September 9, 2019August 31, 2026SAGE, JULIENreporter.nih.gov
Human metabolic variation as a window into cancer initiation and progressionNIHNational Cancer Institute2021 to 2025$4,687,860September 4, 2017August 31, 2030DEBERARDINIS, RALPH Jreporter.nih.gov
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment InterventionsNIHNational Cancer Institute2022 to 2025$4,678,848December 3, 2022August 31, 2026MEZA, RAFAELreporter.nih.gov
DEVELOPMENT, MAINTENANCE, AND PROMOTION OF NCI SPONSORED BEHAVIORAL AND MOBILE HEALTH INITIATIVES.NIHNational Cancer Institute2021 to 2024$4,522,410September 15, 2021September 14, 2025SCHWARZ, MARYreporter.nih.gov
Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer CareNIHNational Cancer Institute2021 to 2025$4,423,867August 1, 2015August 31, 2029FIORE, MICHAEL Creporter.nih.gov
Investigating the Roles of Patient Beliefs, and Physician Communication on Disparities in Lung Cancer ScreeningNIHNational Institute on Minority Health and Health Disparities2021 to 2025$4,149,463September 20, 2021May 31, 2027KALE, MINAL Sreporter.nih.gov
Development of Combination Therapies to Delay/Prevent Acquired Drug ResistanceNIHNational Cancer Institute2021 to 2024$4,095,825September 10, 2018August 31, 2025JANNE, PASI Areporter.nih.gov
Quantitative Imaging Clinical Validation Center at Moffitt Cancer CenterNIHNational Cancer Institute2021 to 2025$3,928,528July 22, 2016August 31, 2028HEINE, JOHN Jreporter.nih.gov
Proteogenomic Predictors of Recurrence in Non-small Cell Lung CancerNIHNational Cancer Institute2022 to 2025$3,920,220June 13, 2022May 31, 2027GOVINDAN, RAMASWAMYreporter.nih.gov
Bringing 4π radiation therapy to the clinicNIHNational Cancer Institute2022 to 2024$3,911,244May 6, 2022April 30, 2025YONEMOTO, JAYreporter.nih.gov
Bay Area Cancer Target Discovery and DevelopmentNIHNational Cancer Institute2022 to 2025$3,880,946September 13, 2022August 31, 2027MCMANUS, MICHAEL Treporter.nih.gov
Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product StandardsNIHNational Cancer Institute2021 to 2022$3,820,230September 20, 2017August 31, 2024HATSUKAMI, DOROTHY Kreporter.nih.gov
Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patientsNIHNational Heart, Lung, and Blood Institute2021 to 2025$3,805,993June 1, 2021May 31, 2027LIAO, ZHONGXINGreporter.nih.gov
Electronic Pediatric Office Systems to Support Treatment for Parental Tobacco UseNIHNational Cancer Institute2021 to 2024$3,780,101January 1, 2020December 31, 2025WINICKOFF, JONATHAN Preporter.nih.gov
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapyNIHNational Cancer Institute2021 to 2024$3,779,781August 15, 2018July 31, 2025GRANDIS, JENNIFER RUBINreporter.nih.gov
Columbus NCORP RFA-CA-18-016NIHNational Cancer Institute2021 to 2025$3,771,688August 1, 2014July 31, 2026RAJAGOPALAN, MALOLAN Sreporter.nih.gov
Studying factors controlling cancer progression and immune recognition in mouse modelsNIHNational Cancer Institute2022 to 2025$3,664,660September 20, 2022August 31, 2029JACKS, TYLER E.reporter.nih.gov
Empathic Communication Skills Training to Reduce Lung Cancer StigmaNIHNational Cancer Institute2021 to 2025$3,592,601September 9, 2021August 31, 2027BANERJEE, SMITAreporter.nih.gov
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial MetabolismNIHNational Cancer Institute2021 to 2025$3,588,137September 22, 2021August 31, 2027DENKO, NICHOLAS C.reporter.nih.gov
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer ImmunotherapyNIHNational Cancer Institute2021 to 2025$3,549,010July 8, 2021February 28, 2027SHARMA, SONIAreporter.nih.gov
Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trialNIHNational Cancer Institute2023 to 2025$3,532,837September 20, 2023August 31, 2028BRICKER, JONATHAN Breporter.nih.gov
University of California and UT Southwestern D-PDTCNIHNational Cancer Institute2023 to 2025$3,532,429August 1, 2023July 31, 2028CARVAJAL CARMONA, LUIS GUILLERMOreporter.nih.gov
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancersNIHNational Cancer Institute2021 to 2025$3,519,313July 12, 2021June 30, 2026DUCKETT, DEREK RONALDreporter.nih.gov
Optimizing Lung Cancer Screening Nodule EvaluationNIHNational Cancer Institute2021 to 2025$3,489,759August 1, 2021July 31, 2026KONG, CHUNG YINreporter.nih.gov
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)NIHNational Heart, Lung, and Blood Institute2023 to 2025$3,483,414September 10, 2020August 31, 2027CASKEY, RACHELreporter.nih.gov
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science CenterNIHNational Cancer Institute2021 to 2025$3,465,294January 2, 2025February 28, 2026LEAL, TICIANAreporter.nih.gov
The MYC Transcription Factor Network and the Path to CancerNIHNational Cancer Institute2021 to 2024$3,449,610September 1, 2018August 31, 2025EISENMAN, ROBERT NEILreporter.nih.gov
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung CancerNIHNational Cancer Institute2021 to 2025$3,448,227December 10, 2020November 30, 2025NEEL, BENJAMIN G.reporter.nih.gov
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated MeasuresNIHNational Cancer Institute2021 to 2025$3,442,093January 1, 2021December 31, 2025MALDONADO, FABIENreporter.nih.gov
Investigating Macrophage Molecular and Functional Diversity in Tumor ImmunityNIHNational Cancer Institute2021 to 2025$3,431,899February 1, 2021January 31, 2026MERAD, MIRIAMreporter.nih.gov
Metformin for chemoprevention of lung cancer in obese subjects at high riskNIHNational Cancer Institute2021 to 2025$3,423,650August 1, 2021July 31, 2027YENDAMURI, SAIKRISHNAreporter.nih.gov
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk PopulationsNIHNational Cancer Institute2022 to 2025$3,421,613October 1, 2022August 31, 2027CARTER-BAWA, LISAreporter.nih.gov
Optimizing Lung Cancer Screening in Cancer SurvivorsNIHNational Cancer Institute2021 to 2025$3,415,788July 15, 2021June 30, 2027WISNIVESKY, JUAN Preporter.nih.gov
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics DataNIHNational Cancer Institute2021 to 2025$3,377,653January 22, 2021December 31, 2026CAI, QIUYINreporter.nih.gov
Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatmentNIHNational Cancer Institute2023 to 2025$3,343,401September 19, 2023August 31, 2028POTOSKY, ARNOLD Lreporter.nih.gov
Multilevel Interventions to Increase Adherence to Lung Cancer ScreeningNIHNational Cancer Institute2021 to 2025$3,340,674July 15, 2021June 30, 2027WERNLI, KAREN Jreporter.nih.gov
Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer riskNIHNational Institute on Minority Health and Health Disparities2021 to 2025$3,331,422August 24, 2021April 30, 2027CAI, QIUYINreporter.nih.gov
Stroger Hospital of Cook County (SHCC) MU-NCORP RenewalNIHNational Cancer Institute2021 to 2024$3,305,824August 16, 2014March 31, 2025TAMKUS, DEIMANTEreporter.nih.gov
A community-based trial of a voluntary smoke-free home intervention in permanent supportive housing for formerly homeless adultsNIHNational Cancer Institute2021 to 2025$3,303,677March 3, 2021February 28, 2026VIJAYARAGHAVAN, MAYAreporter.nih.gov
The B7x pathways in the tumor microenvironmentNIHNational Cancer Institute2021 to 2025$3,299,614July 1, 2014November 30, 2026ZANG, XINGXINGreporter.nih.gov
Novel metabolomic contrast probes for human lung cancer characterizationNIHNational Cancer Institute2022 to 2025$3,297,251September 1, 2022August 31, 2027FARRAR, CHRISTIAN Treporter.nih.gov
Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural HypothesisNIHNational Cancer Institute2021 to 2025$3,292,953July 1, 2021June 30, 2026RUIZ, JOHN Mreporter.nih.gov
Expanding population-level interventions to help more low-income smokers quitNIHNational Cancer Institute2021 to 2023$3,284,616July 23, 2019June 30, 2024KREUTER, MATTHEW W.reporter.nih.gov
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive AdultsNIHNational Institute on Drug Abuse2021 to 2024$3,280,008July 1, 2020May 31, 2025FANTRY, LORI Ereporter.nih.gov
Detecting and locating cancer for patients with CT-detected lung nodulesNIHNational Cancer Institute2022 to 2025$3,224,369September 14, 2022August 31, 2027ZHOU, XIANGHONG JASMINEreporter.nih.gov
Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal CancerNIHNational Cancer Institute2021 to 2024$3,217,584April 2, 2020March 31, 2026SUN, VIRGINIA CHIH-YIreporter.nih.gov
Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancerNIHNational Cancer Institute2021 to 2025$3,194,826January 1, 2025December 31, 2026SEGAL, LEOPOLDO NICOLASreporter.nih.gov
Reducing lung cancer by decoding the link between neighborhood exposure and biological responses (RECODE)NIHNational Institute on Minority Health and Health Disparities2021 to 2025$3,171,260May 6, 2021January 31, 2027KIM, SAGE J.reporter.nih.gov
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung CancerNIHNational Cancer Institute2021 to 2025$3,159,973September 16, 2021August 31, 2026WU, JIAreporter.nih.gov
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunityNIHNational Cancer Institute2023 to 2025$3,154,814September 19, 2023August 31, 2028BROWN, BRIAN Dreporter.nih.gov
Immunotherapy via engineered therapeutic programs in tumors using RNANIHNational Cancer Institute2021 to 2025$3,154,064September 20, 2021August 31, 2027WEISS, RONreporter.nih.gov
Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patientNIHNational Cancer Institute2021 to 2025$3,134,857July 13, 2021June 30, 2027POGHOSYAN, HERMINEreporter.nih.gov
Optimizing Individualized and Adaptive mHealth Interventions via Control Systems Engineering MethodsNIHNational Cancer Institute2021 to 2024$3,121,021July 14, 2020June 30, 2026HEKLER, ERICreporter.nih.gov
Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung CancerNIHNational Cancer Institute2022 to 2025$3,113,004August 8, 2022July 31, 2027PHELPS, MITCH Areporter.nih.gov
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy AssayNIHNational Cancer Institute2022 to 2025$3,075,394September 1, 2022August 31, 2027WU, YUNreporter.nih.gov
Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged AdultsNIHNational Cancer Institute2021 to 2025$3,067,733April 1, 2021March 31, 2026KENDZOR, DARLA ELIZABETHreporter.nih.gov
Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary NodulesNIHNational Cancer Institute2021 to 2025$3,035,750May 1, 2021April 30, 2027GROGAN, ERIC Lreporter.nih.gov
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in AppalachiaNIHNational Cancer Institute2022 to 2025$3,031,959September 8, 2022August 31, 2027LITTLE, MELISSA ASHLEYreporter.nih.gov
DCTD Cancer ImagingNIHNational Cancer Institute2021 to 2024$3,009,076September 26, 2008August 30, 2019HEIMBROOK, DAVIDreporter.nih.gov
Translating buccal nanocytology for lung cancer screening into clinical practiceNIHNational Cancer Institute2021 to 2025$3,005,920April 15, 2018July 31, 2029BACKMAN, VADIMreporter.nih.gov
Building Implementation Science Research Capacity to advance cancer prevention and care in Uganda and ZambiaNIHNational Cancer Institute2021 to 2024$3,003,899September 15, 2021August 31, 2026WIPFLI, HEATHER Lreporter.nih.gov
Local Flavor Policies to Enhance Equity in TobaccoNIHNational Cancer Institute2021 to 2025$2,999,270April 8, 2021March 31, 2027ROSE, SHYANIKA Wreporter.nih.gov
Trends and outcomes of lung cancer screening among people with and without HIV in the USNIHNational Cancer Institute2025$2,991,283September 23, 2025August 31, 2029ISLAM, JESSICA YASMINEreporter.nih.gov
Botswana Smoking Abstinence Reinforcement Trial (BSMART)NIHNational Cancer Institute2022 to 2025$2,990,959September 15, 2022August 31, 2027CHARURAT, MANHATTAN Ereporter.nih.gov
Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT)NIHNational Cancer Institute2021 to 2025$2,979,791September 17, 2021August 31, 2027VIDRINE, DAMON J.reporter.nih.gov
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancerNIHNational Cancer Institute2021 to 2025$2,963,965February 1, 2021January 31, 2027CARBONE, DAVID P.reporter.nih.gov
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic responseNIHNational Cancer Institute2021 to 2025$2,957,123June 1, 2021May 31, 2026BYERS, LAUREN AVERETTreporter.nih.gov
Mechanistic Risk Prediction of Radiation Therapy CardiotoxicityNIHNational Heart, Lung, and Blood Institute2021 to 2024$2,943,376July 15, 2020June 30, 2026KY, BONNIEreporter.nih.gov
Molecular mechanisms underlying lineage plasticity in prostate cancerNIHNational Cancer Institute2021 to 2025$2,937,823April 1, 2025March 31, 2027BELTRAN, HIMISHAreporter.nih.gov
(PQ1) HIV-infected T-cell exosomes in lung cancer progressionNIHNational Cancer Institute2021 to 2024$2,935,014July 1, 2020June 30, 2025JIN, GEreporter.nih.gov
Intercepting progression from pre-invasive to invasive lung adenocarcinomaNIHNational Cancer Institute2021 to 2023$2,932,940September 25, 2019February 28, 2025ALTORKI, NASSER KHALEDreporter.nih.gov
SMART Cancer Care Teams: Enhancing EHR Communication to Improve Interprofessional TeamworkNIHNational Cancer Institute2022 to 2025$2,924,499July 1, 2022June 30, 2027TU, SHIN-PINGreporter.nih.gov
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung CancerNIHNational Cancer Institute2021 to 2025$2,890,525December 1, 2024November 30, 2026SCOTT, JACOB GARDINIERreporter.nih.gov
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin MatricesNIHNational Cancer Institute2021 to 2025$2,877,928March 1, 2021February 28, 2026PECOT, CHAD Vreporter.nih.gov
Tumor selective inhibition of the WNT pathwayNIHNational Cancer Institute2022 to 2025$2,875,859September 22, 2022August 31, 2027DOW, LUKAS EDWARDreporter.nih.gov
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer TherapiesNIHNational Cancer Institute2021 to 2025$2,860,221September 15, 2021August 31, 2026KINAHAN, PAUL E.reporter.nih.gov
Construal level as a novel pathway for affect regulation and cancer controlNIHNational Cancer Institute2021 to 2024$2,836,437April 1, 2020March 31, 2026BERKMAN, ELLIOT TODDreporter.nih.gov
Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + SmokersNIHNational Heart, Lung, and Blood Institute2021 to 2022$2,835,005February 10, 2020January 31, 2024GROSS, ROBERTreporter.nih.gov
Exosomes as carriers of cancer therapeuticsNIHNational Cancer Institute2021 to 2025$2,827,587September 14, 2021August 31, 2027RAMESH, RAJAGOPALreporter.nih.gov
Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung CancerNIHNational Cancer Institute2021 to 2025$2,813,174July 23, 2021June 30, 2026POLITI, KATERINA ABIGAILreporter.nih.gov
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancerNIHNational Cancer Institute2021 to 2025$2,809,344August 1, 2021July 31, 2026LITTMAN, DANreporter.nih.gov
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancerNIHNational Cancer Institute2021 to 2025$2,807,941July 1, 2025June 30, 2027LISSANU, YONATHANreporter.nih.gov
Improving smoking abstinence outcomes in the African American community through extended treatmentNIHNational Cancer Institute2022 to 2025$2,801,719May 1, 2022April 30, 2027COX, LISA SANDERSONreporter.nih.gov
Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in IndiaNIHNational Cancer Institute2021 to 2024$2,800,655June 1, 2020May 31, 2026VISWANATH, KASISOMAYAJULAreporter.nih.gov
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancerNIHNational Cancer Institute2022 to 2025$2,799,371June 1, 2022May 31, 2027MUKHERJEE, SEMANTIreporter.nih.gov
Addressing Rural Cancer Disparities via Proactive Smoking Cessation Treatment within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic VisitNIHNational Cancer Institute2022 to 2025$2,798,003September 8, 2022August 31, 2028DAHNE, JENNIFER RENEEreporter.nih.gov
DNA evaluation of fragments for early interception (DELFI) of Lung cancerNIHNational Cancer Institute2023 to 2025$2,789,019July 17, 2023June 30, 2028VELCULESCU, VICTOR E.reporter.nih.gov
Designer Molecular Probes for Biomedical ApplicationsNIHNational Institute of General Medical Sciences2021 to 2025$2,788,245September 1, 2019April 30, 2030DMOCHOWSKI, IVAN JULIANreporter.nih.gov
Addressing disparities in tobacco-related diseases by understanding the tobacco industry strategiesNIHNational Cancer Institute2022 to 2025$2,769,201August 1, 2022July 31, 2027BIALOUS, STELLA AGUINAGAreporter.nih.gov
Multi-cancer early detection using cell-free DNA methylome analysisNIHNational Cancer Institute2023 to 2025$2,757,500September 19, 2023August 31, 2028ZHOU, XIANGHONG JASMINEreporter.nih.gov
Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRINIHNational Cancer Institute2021 to 2025$2,741,941September 17, 2021August 31, 2027RUSET, IULIAN CONSTANTINreporter.nih.gov
Identifying and Targeting Mechanisms for Membrane Signaling in Human CancerNIHNational Cancer Institute2021 to 2025$2,736,865December 10, 2020November 30, 2025SWEET-CORDERO, ERIC ALEJANDROreporter.nih.gov
Establishing smoke-free homes with families involved in child protective services: An effectiveness-implementation trial of an integrated programNIHNational Cancer Institute2021 to 2025$2,704,547January 1, 2021December 31, 2026SELF-BROWN, SHANNON RENEEreporter.nih.gov
Precision prevention strategy to increase uptake and engagement in lung cancer screening and smoking cessation treatmentNIHNational Cancer Institute2022 to 2025$2,692,512March 21, 2022February 28, 2027RAMSEY, ALEX TAYLORreporter.nih.gov
Development of a first-in-class mEGFR dimerization inhibitorNIHNational Cancer Institute2021 to 2024$2,692,158April 3, 2020March 31, 2026NYATI, MUKESH K.reporter.nih.gov
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2NIHNational Cancer Institute2021 to 2025$2,686,065April 1, 2021September 30, 2026KURIE, JONATHAN Mreporter.nih.gov
The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancerNIHNational Cancer Institute2021 to 2025$2,641,121September 1, 2020May 31, 2027ROBINSON, JASON Dreporter.nih.gov
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policyNIHNational Cancer Institute2021 to 2025$2,631,104June 1, 2020February 28, 2027BRAITHWAITE, DEJANA Kreporter.nih.gov
Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes (Clinical and public health approaches to tobacco cessation in South Africa supplement)NIHNational Institute on Drug Abuse2021 to 2024$2,627,377September 1, 2020July 31, 2025REDDY, KRISHNA Preporter.nih.gov
Understanding the role of area-level factors, smoking, and epigenetics in lung cancer risk across populations groupsNIHNational Cancer Institute2022 to 2025$2,625,326July 1, 2022June 30, 2027CHENG, IONA Creporter.nih.gov
Elucidating Lung Cancer Etiology Among Asian American Female Never SmokersNIHNational Institute on Minority Health and Health Disparities2021 to 2024$2,617,930February 1, 2020November 30, 2025GOMEZ, SCARLETT Lreporter.nih.gov
Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancersNIHNational Cancer Institute2022 to 2025$2,615,144June 14, 2022May 31, 2027NIMMAGADDA, SRIDHARreporter.nih.gov
Engineering Dual-Targeted Nanoplatforms to Effectively Treat NSCLC.NIHNational Institute of Biomedical Imaging and Bioengineering2022 to 2025$2,613,356September 30, 2022May 31, 2027KANNAN, RAGHURAMANreporter.nih.gov
PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancerNIHNational Cancer Institute2023 to 2025$2,602,500July 6, 2023August 31, 2027NGAMCHERDTRAKUL, WORAPOLreporter.nih.gov
Personalization and Failure Testing of Dual Switch Gene Drives in Lung CancerNIHNational Cancer Institute2021 to 2025$2,591,489September 10, 2021August 31, 2026PRITCHARD, JUSTINreporter.nih.gov
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancerNIHNational Cancer Institute2022 to 2025$2,583,947April 1, 2021March 31, 2027BRENTJENS, RENIER JOSEPHreporter.nih.gov
Functional Genomics of LINE-1 RetrotranspositionNIHNational Institute of Environmental Health Sciences2022 to 2025$2,575,492April 21, 2022January 31, 2027RAMOS, KENNETH S.reporter.nih.gov
Comprehensive molecular characterization of lung cancers in five racial/ethnic groups with disparate riskNIHNational Institute on Minority Health and Health Disparities2021 to 2024$2,566,329February 25, 2020December 31, 2025PARK, SUNGSHIM LANIreporter.nih.gov
Provider Support and Patient Outreach in Lung Cancer ScreeningNIHNational Cancer Institute2022 to 2025$2,561,580July 1, 2022June 30, 2027MYERS, RONALD E.reporter.nih.gov
Factors Associated with High Quality Care for Patients with Lung CancerNIHNational Institute on Minority Health and Health Disparities2022 to 2025$2,547,019September 21, 2022May 31, 2027GROSS, CARY P.reporter.nih.gov
Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancerNIHNational Cancer Institute2021 to 2025$2,543,302February 19, 2021January 31, 2027KADARA, HUMAMreporter.nih.gov
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapyNIHNational Cancer Institute2022 to 2025$2,537,016June 1, 2022May 31, 2027LANDAU, DANreporter.nih.gov
Early Detection and Diagnosis of Lung Cancer with EndomicroscopyNIHNational Cancer Institute2021 to 2025$2,524,841January 1, 2021December 31, 2026SUTER, MELISSA Jreporter.nih.gov
Role of METTL3 and the m6A Epitranscriptome in cancerNIHNational Cancer Institute2021 to 2024$2,524,158December 11, 2019November 30, 2024GREGORY, RICHARD I.reporter.nih.gov
Digital Media for Cancer Control: Randomized Controlled Trial and Dose Response EffectsNIHNational Cancer Institute2021 to 2024$2,493,249September 17, 2020May 31, 2026EVANS, W. DOUGLASreporter.nih.gov
In vivo imaging of mitochondria structure and function in therapy resistant lung tumorsNIHNational Cancer Institute2022 to 2025$2,487,108July 1, 2022June 30, 2027SHACKELFORD, DAVID Breporter.nih.gov
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)NIHNational Heart, Lung, and Blood Institute2021 to 2022$2,480,652September 10, 2020August 31, 2023DONENBERG, GERI Rreporter.nih.gov
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agentNIHNational Cancer Institute2022 to 2024$2,473,054September 1, 2022August 31, 2025ZHANG, KEreporter.nih.gov
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the LungNIHNational Cancer Institute2021 to 2024$2,470,692April 1, 2020March 31, 2026MAEDA, YUTAKAreporter.nih.gov
Dissecting the interplay between aging, genotype and the microenvironment in lung cancerNIHNational Institute on Aging2021 to 2025$2,470,064September 30, 2021June 30, 2026WINSLOW, MONTE MEIERreporter.nih.gov
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancerNIHNational Cancer Institute2021 to 2024$2,463,397August 1, 2020April 30, 2026DIEHN, MAXIMILIANreporter.nih.gov
Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message ApproachesNIHNational Cancer Institute2021 to 2024$2,457,120January 15, 2020March 19, 2025TAN, ANDY SLreporter.nih.gov
Mechanistic factors limiting utility of adenovirus vectors for treatment of neoplaNIHNational Cancer Institute2022 to 2025$2,454,583May 5, 2022April 30, 2027SHAYAKHMETOV, DMITRYreporter.nih.gov
Risk Stratification for COPD Exacerbations with CT Analysis and Multidimensional Trajectory SubtypingNIHNational Heart, Lung, and Blood Institute2023 to 2025$2,448,553April 15, 2023February 29, 2028ROSS, JAMESreporter.nih.gov
Novel DNA damage response therapeutics targeting replication protein ANIHNational Cancer Institute2021 to 2025$2,445,263July 1, 2021June 30, 2027TURCHI, JOHN J.reporter.nih.gov
Electronic Cigarette-derived Oxidants and their Impact on Lung Cancer DevelopmentNIHNational Cancer Institute2021 to 2025$2,445,242June 5, 2020May 31, 2027FOULDS, JONATHANreporter.nih.gov
Comparative-Effectiveness of Pretreatment Lung Cancer Nodal StagingNIHNational Cancer Institute2022 to 2025$2,437,399January 17, 2022June 30, 2026FARJAH, FARHOODreporter.nih.gov
Evaluation of genetic, clinical and environmental risk factors to establish effective screening strategies for second primary lung cancerNIHNational Cancer Institute2021 to 2024$2,434,380May 1, 2018April 30, 2026HAN, SUMMER Sreporter.nih.gov
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790MNIHNational Cancer Institute2021 to 2025$2,408,596December 1, 2015November 30, 2025ECK, MICHAEL Jreporter.nih.gov
Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood AssaysNIHNational Cancer Institute2022 to 2025$2,404,930December 20, 2021November 30, 2026BOWEN, STEPHEN R.reporter.nih.gov
Liquid biopsy of solitary pulmonary nodule with extracellular vesiclesNIHNational Cancer Institute2021 to 2025$2,402,652September 21, 2021August 31, 2026WAN, YUANreporter.nih.gov
A pro-metastatic secretory pathway activated by p53 loss in lung cancerNIHNational Cancer Institute2021 to 2025$2,399,783July 1, 2021December 31, 2026KURIE, JONATHAN Mreporter.nih.gov
Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancerNIHNational Cancer Institute2022 to 2025$2,389,102September 1, 2022July 31, 2027KADARA, HUMAMreporter.nih.gov
Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop SmokingNIHNational Cancer Institute2021 to 2024$2,383,412June 1, 2020May 31, 2026BRICKER, JONATHAN Breporter.nih.gov
Macro-vasculature: A Novel Image Biomarker of Lung CanceNIHNational Cancer Institute2021 to 2024$2,378,544January 13, 2020December 31, 2025PU, JIANTAOreporter.nih.gov
Histone Deacetylation Signaling in Aging and Cancer PathwaysNIHNational Cancer Institute2021 to 2025$2,374,193July 9, 2021August 31, 2026CHUA, KATRIN F.reporter.nih.gov
Addressing racial disparities in lung cancer screeningNIHNational Cancer Institute2021 to 2025$2,367,378April 5, 2021March 31, 2027ALDRICH, MELINDAreporter.nih.gov
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung CancerNIHNational Cancer Institute2022 to 2025$2,357,606September 1, 2022August 31, 2027LASTWIKA, KRISTIN Jreporter.nih.gov
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation TherapyNIHNational Cancer Institute2021 to 2024$2,352,523March 1, 2020February 28, 2026BERBECO, ROSS I.reporter.nih.gov
Deregulation of long noncoding RNAs in cancerNIHNational Cancer Institute2022 to 2025$2,349,232August 1, 2022July 31, 2027DIMITROVA, NADYA Mreporter.nih.gov
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIVNIHNational Cancer Institute2021 to 2024$2,347,827September 13, 2019August 31, 2025SCHNOLL, ROBERT ADAMreporter.nih.gov
The Impact of Tobacco Control Policies on Health Equity in the United States - MERIT ExtensionNIHNational Cancer Institute2021 to 2024$2,345,823December 19, 2017November 30, 2024FLEISCHER, NANCYreporter.nih.gov
The Interplay of ENDS and Tobacco Control Policy: Impact on the Population Harms of TobaccoNIHNational Cancer Institute2022 to 2025$2,344,619July 1, 2022June 30, 2027MACIOSEK, MICHAEL Vreporter.nih.gov
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIVNIHNational Institute on Drug Abuse2021 to 2023$2,343,499May 15, 2019February 28, 2025O'CLEIRIGH, CONALL MICHAELreporter.nih.gov
Investigating the heterogeneity of glucose transport in lung adenocarcinomaNIHNational Cancer Institute2021 to 2025$2,335,147February 1, 2020January 31, 2026SCAFOGLIO, CLAUDIOreporter.nih.gov
Implications of metabolic heterogeneity on collective lung cancer cell invasionNIHNational Cancer Institute2021 to 2025$2,328,006April 5, 2021March 31, 2027SHANMUGAM, MALATHY (MALA)reporter.nih.gov
Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved SmokersNIHNational Cancer Institute2021 to 2024$2,315,994September 7, 2019November 30, 2025VIDRINE, DAMON J.reporter.nih.gov
A randomized controlled trial to support smoke-free policy compliance in public housingNIHNational Cancer Institute2021 to 2025$2,315,269August 1, 2020November 30, 2026HERNANDEZ, DIANAreporter.nih.gov
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffoldNIHNational Cancer Institute2022 to 2025$2,312,303July 1, 2022June 30, 2027WU, JIEreporter.nih.gov
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLCNIHNational Cancer Institute2022 to 2025$2,310,416June 17, 2022May 31, 2027KANNAN, RAGHURAMANreporter.nih.gov
Improving access to multidisciplinary cancer care and patient outcomes by targeting physician networksNIHNational Cancer Institute2021 to 2025$2,308,736July 1, 2025June 30, 2027MOEN, ERIKAreporter.nih.gov
HFH-MSU CSRN ACCrual Enrollment and Screening SiteNIHNational Cancer Institute2024 to 2025$2,289,116March 7, 2025December 31, 2027NESLUND-DUDAS, CHRISTINE MARIEreporter.nih.gov
HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapyNIHNational Cancer Institute2023 to 2025$2,286,846August 1, 2023July 31, 2028GARON, EDWARD Breporter.nih.gov
Role of IRF2 in cancer immune evasion and immunotherapyNIHNational Cancer Institute2021 to 2024$2,279,029June 29, 2020May 31, 2026ROCK, KENNETH Lreporter.nih.gov
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life ExpectancyNIHNational Cancer Institute2022 to 2025$2,272,686June 15, 2022May 31, 2027TOUMAZIS, IAKOVOSreporter.nih.gov
Intrapleural immunotherapeutic nanoparticles for MPE treatmentNIHNational Cancer Institute2021 to 2025$2,266,085August 1, 2021July 31, 2027ZHAO, DAWENreporter.nih.gov
Cellular plasticity gives rise to phenotypic equilibrium in small cell lung carcinomaNIHNational Cancer Institute2022 to 2025$2,265,527September 1, 2022August 31, 2027ABAZEED, MOHAMED E.reporter.nih.gov
Phone Enabled Implementation of Cessation Support (PHOENICS)NIHNational Cancer Institute2022 to 2025$2,264,697September 9, 2022August 31, 2027SALLOUM, RAMZI GEORGEreporter.nih.gov
Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer ImmunotherapyNIHNational Cancer Institute2022 to 2025$2,263,208July 11, 2022June 30, 2027WANG, JUNreporter.nih.gov
Molecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitorsNIHNational Cancer Institute2021 to 2024$2,260,368April 1, 2020September 30, 2025HEYMACH, JOHN V.reporter.nih.gov
Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and SettingsNIHNational Cancer Institute2021 to 2025$2,257,907September 20, 2017May 31, 2028HENDERSON, LOUISEreporter.nih.gov
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.NIHNational Cancer Institute2021 to 2023$2,256,673April 23, 2019March 31, 2025POLITI, KATERINA ABIGAILreporter.nih.gov
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung CancerNIHNational Cancer Institute2021 to 2024$2,243,532September 23, 2021November 30, 2025NGAMCHERDTRAKUL, WORAPOLreporter.nih.gov
A Personalized Digital Outreach Intervention for Lung Cancer ScreeningNIHNational Cancer Institute2021 to 2024$2,241,011January 1, 2020December 31, 2025MILLER, DAVID Preporter.nih.gov
Reducing cardiac toxicity with deep learning and MRI-guided radiation therapyNIHNational Heart, Lung, and Blood Institute2021 to 2024$2,238,763August 23, 2021July 31, 2026GLIDE-HURST, CARRI KAYEreporter.nih.gov
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modelingNIHNational Cancer Institute2023 to 2025$2,229,645August 1, 2023July 31, 2028SCOTT, JACOB GARDINIERreporter.nih.gov
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung CancerNIHNational Cancer Institute2021 to 2025$2,227,994July 1, 2025June 30, 2027SCHALPER, KURT Areporter.nih.gov
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer CachexiaNIHNational Cancer Institute2021 to 2025$2,226,892May 1, 2024April 30, 2027TARATULA, OLEHreporter.nih.gov
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsyNIHNational Cancer Institute2021 to 2025$2,223,062August 1, 2021July 31, 2026TONER, MEHMETreporter.nih.gov
Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer developmentNIHNational Cancer Institute2022 to 2025$2,222,275March 15, 2022February 28, 2027ZWEIER, JAY LOUISreporter.nih.gov
FRONTIERS: Foreign-Born Latinos Cancer ScreeningNIHNational Cancer Institute2022 to 2025$2,221,298May 20, 2022April 30, 2027HEINTZMAN, JOHN D.reporter.nih.gov
Air Pollution and Neighborhood Stressors as Determinants of Non-Small Cell Lung Cancer (NSCLC) Mutation Patterns and RecurrenceNIHNational Cancer Institute2024 to 2025$2,217,862May 10, 2024April 30, 2029ERHUNMWUNSEE, LORETTAreporter.nih.gov
Progenitor cell states contributing to aging and lung cancerNIHNational Cancer Institute2021 to 2025$2,206,534September 24, 2021August 31, 2026HAIGIS, MARCIAreporter.nih.gov
Metabolism Informed Smoking Treatment in Medicaid and Medicare Patients: The MIST RCTNIHNational Cancer Institute2021 to 2023$2,201,804April 8, 2019September 30, 2024TINDLE, HILARY A.reporter.nih.gov
Rapid and affordable magneto-nanosensors for ctDNA-guided lung cancer managementNIHNational Cancer Institute2021 to 2024$2,197,559August 2, 2021July 31, 2025WANG, SHAN X.reporter.nih.gov
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunologyNIHNational Cancer Institute2021 to 2024$2,192,022April 1, 2020March 31, 2025JOSHI, NIKHILreporter.nih.gov
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasisNIHNational Cancer Institute2021 to 2025$2,189,875March 5, 2021February 28, 2027PENDERGAST, ANN MARIEreporter.nih.gov
Housing assistance, Outcomes, Medicare, and SEER (HOMES): using a novel data linkage to understand cancer inequitiesNIHNational Cancer Institute2022 to 2025$2,188,717July 1, 2022June 30, 2027POLLACK, CRAIG EVANreporter.nih.gov
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancerNIHNational Cancer Institute2022 to 2025$2,185,961April 1, 2021March 31, 2026BERGER, ALICEreporter.nih.gov
Therapeutic strategies against EGFR exon 20 mutant lung cancerNIHNational Cancer Institute2021 to 2024$2,179,752December 1, 2019November 30, 2024HEYMACH, JOHN V.reporter.nih.gov
Genetic dissection of oncogenic Kras signalingNIHNational Cancer Institute2021 to 2025$2,178,492July 1, 2021June 30, 2026WINSLOW, MONTE MEIERreporter.nih.gov
Understanding the Multilevel Drivers of Liver Cancer DisparitiesNIHNational Cancer Institute2021 to 2023$2,174,412August 16, 2019July 31, 2025SHARIFF-MARCO, SALMAreporter.nih.gov
Role of PI3Kgamma in Tumor Progression and MetastasisNIHNational Cancer Institute2021 to 2025$2,165,420April 1, 2012August 31, 2028VARNER, JUDITH Areporter.nih.gov
Trial of a harm reduction strategy for people with HIV who smoke cigarettesNIHNational Cancer Institute2023 to 2025$2,162,300May 1, 2023April 30, 2028SHUTER, JONATHANreporter.nih.gov
Structural and molecular determinants of protein phosphatase 2A function in lung cancerNIHNational Cancer Institute2021 to 2023$2,146,755June 1, 2019May 31, 2025NARLA, GOUTHAMreporter.nih.gov
A no-gold-standard framework to objectively evaluate quantitative imaging methods with patient dataNIHNational Institute of Biomedical Imaging and Bioengineering2021 to 2025$2,142,231April 1, 2021December 31, 2026JHA, ABHINAV Kreporter.nih.gov
The Thromboxane-Prostanoid Receptor in Radiation-Induced Pulmonary FibrosisNIHNational Cancer Institute2023 to 2025$2,141,378August 22, 2023July 31, 2028WEST, JAMES Dreporter.nih.gov
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase DNIHNational Cancer Institute2022 to 2025$2,138,837December 1, 2021November 30, 2026HUANG, RONGreporter.nih.gov
Modulation of Mcl-1 for Treatment of Lung CancerNIHNational Cancer Institute2021 to 2025$2,130,060June 1, 2021May 31, 2027DENG, XINGMINGreporter.nih.gov
Structural and molecular dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseasesNIHNational Institute of General Medical Sciences2022 to 2025$2,124,759March 10, 2022February 28, 2027QU, ZHAOXIAreporter.nih.gov
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesotheliomaNIHNational Cancer Institute2021 to 2024$2,116,571June 1, 2019May 31, 2025ADUSUMILLI, PRASAD S.reporter.nih.gov
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain CancersNIHNational Cancer Institute2021 to 2023$2,114,438May 15, 2018November 30, 2024DUCKETT, DEREK RONALDreporter.nih.gov
Ligand-Directed KRAS G12V Mutant-Specific TherapeuticsNIHNational Cancer Institute2023 to 2025$2,113,685July 5, 2023June 30, 2026STANLAND, LYLAreporter.nih.gov
Advancing CAR T cell therapy for solid tumorsNIHOffice of the Director, National Institutes of Health2021 to 2025$2,112,916September 14, 2021August 31, 2026AHMED, JALALreporter.nih.gov
Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancerNIHNational Cancer Institute2022 to 2025$2,112,899July 1, 2022June 30, 2027LISSANU, YONATHANreporter.nih.gov
Determine genotypic, phenotypic and evolutionary trajectories of treatment resistance to radiotherapy.NIHNational Cancer Institute2025$2,105,127September 23, 2025August 31, 2029GOPAL, PRIYANKAreporter.nih.gov
Improving the Timeliness and Quality of Care for Rural Lung and Head-and-Neck Cancer PatientsNIHNational Cancer Institute2021 to 2025$2,093,504July 1, 2021June 30, 2027BORRAYO, EVELINNreporter.nih.gov
Improved methods for inference of genotype-specific response to environmental toxinsNIHNational Institute of Environmental Health Sciences2021 to 2023$2,092,346February 1, 2019January 31, 2025AYROLES, JULIENreporter.nih.gov
Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung CancerNIHNational Cancer Institute2022 to 2025$2,091,593February 24, 2022January 31, 2028KOZOWER, BENJAMIN Dreporter.nih.gov
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLCNIHNational Cancer Institute2021 to 2022$2,087,996September 3, 2018August 31, 2024HANN, CHRISTINE L.reporter.nih.gov
METTL3 in chromium-induced angiogenesis and carcinogenesisNIHNational Institute of Environmental Health Sciences2022 to 2025$2,077,900April 29, 2022January 31, 2027MCMAHON, STEVEN B.reporter.nih.gov
Mechanisms driving lung cancer evolution during targeted kinase inhibitor treatmentNIHNational Cancer Institute2021 to 2024$2,073,986April 1, 2020March 31, 2026HATA, AARON Nreporter.nih.gov
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancersNIHNational Cancer Institute2022 to 2025$2,067,058January 1, 2022December 31, 2026GORDAN, JOHN Dreporter.nih.gov
Aberrant Glycogen in Lung Adenocarcinoma TumorigenesisNIHNational Cancer Institute2022 to 2025$2,065,800July 1, 2022June 30, 2027SUN, RAMON C.reporter.nih.gov
TELEhealth Shared decision-making COaching for lung cancer screening in Primary care (TELESCOPE)NIHNational Heart, Lung, and Blood Institute2023 to 2025$2,064,881April 1, 2022March 31, 2027KINNEY, ANITA Y.reporter.nih.gov
Multi-cellular interactions defining the human brain metastatic nicheNIHNational Cancer Institute2023 to 2025$2,058,782May 1, 2023April 30, 2028IZAR, BENJAMINreporter.nih.gov
Metabolic activation of nitroarenes and Nrf2-Keap1NIHNational Institute of Environmental Health Sciences2021 to 2025$2,044,114May 8, 2019February 28, 2030PENNING, TREVOR Mreporter.nih.gov
Promoting Equity of Cancer Screening and Follow-up for Lung Cancer.NIHNational Cancer Institute2023 to 2025$2,037,945June 9, 2023May 31, 2028DOUBENI, CHYKE ABADAMAreporter.nih.gov
Metabolism of Carcinogenic Tobacco-Specific NitrosaminesNIHNational Cancer Institute2021 to 2024$2,030,422April 1, 1999November 30, 2024HECHT, STEPHEN Sreporter.nih.gov
A smoke-free home intervention in federally subsidized housingNIHNational Institute on Minority Health and Health Disparities2023 to 2025$2,026,944August 15, 2023February 29, 2028VIJAYARAGHAVAN, MAYAreporter.nih.gov
Optimizing Tobacco Treatment Delivery for People Living with HIVNIHNational Cancer Institute2021 to 2025$2,012,292March 15, 2021February 28, 2027ROJEWSKI, ALANAreporter.nih.gov
Immunoregulatory role of lung-resident club cell factors in lung cancerNIHNational Cancer Institute2023 to 2025$2,003,505February 1, 2023January 31, 2028MITTAL, VIVEKreporter.nih.gov
BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERSTASK ORDER TITLE: FURTHER DEVELOPMENT OF MITOCHONDRIA-TARGETED HONOKIOLNIHNational Cancer Institute2024 to 2025$2,002,559September 25, 2025March 24, 2028reporter.nih.gov
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulationNIHNational Cancer Institute2023 to 2024$2,001,990April 1, 2023August 31, 2025BEVERLIN II, BRYCEreporter.nih.gov
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and FibrosisNIHNational Heart, Lung, and Blood Institute2021 to 2022$2,000,000June 1, 2020May 31, 2023GARCIA, JOE G. N.reporter.nih.gov
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapyNIHNational Cancer Institute2021 to 2022$2,000,000April 3, 2020March 31, 2023ZHENG, PANreporter.nih.gov
A multicenter study in bronchoscopy combining Stimulated Raman Histology with Artificial intelligence for rapid lung cancer detection - The ON-SITE studyNIHNational Cancer Institute2023 to 2024$2,000,000March 1, 2023February 28, 2026FREUDIGER, CHRISTIANreporter.nih.gov
Aerosolized Epigenetic Therapy for Metastatic Lung CancerNIHNational Cancer Institute2023 to 2025$2,000,000September 19, 2023November 30, 2025REED, MATTHEWreporter.nih.gov
Prospective validation of a radiomics-based multi-modal predictive model for metastatic non-small cell lung cancer patients treated with PD-1 immunotherapyNIHNational Cancer Institute2024 to 2025$2,000,000September 13, 2024August 31, 2026JORDAN, PETRreporter.nih.gov
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNANIHNational Cancer Institute2024 to 2025$1,999,999September 17, 2024August 31, 2026BARRETT, MICHAEL Treporter.nih.gov
Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung CancerNIHNational Cancer Institute2021 to 2023$1,999,833September 17, 2019August 31, 2025ARGUN, AVNI Areporter.nih.gov
Development of a lung cancer subtyping diagnosticNIHNational Cancer Institute2024 to 2025$1,999,191September 18, 2024August 31, 2026GARNER, HAROLD Rreporter.nih.gov
Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for CessationNIHNational Cancer Institute2023 to 2025$1,999,064February 15, 2022January 31, 2027STEINBERG, MICHAEL B.reporter.nih.gov
Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agentNIHNational Cancer Institute2022 to 2023$1,998,535September 8, 2022May 31, 2024BENSEN, ERIC SCOTTreporter.nih.gov
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid TumorsNIHNational Cancer Institute2023 to 2024$1,998,400September 19, 2023August 31, 2025MARATHI, UPENDRAreporter.nih.gov
PET imaging of radiation induced lung injuryNIHNational Cancer Institute2022 to 2023$1,996,724May 4, 2020May 31, 2025HUMBLET, VALERIEreporter.nih.gov
Communicating Waterpipe Tobacco Harms to Reduce Use among Young AdultsNIHNational Cancer Institute2021 to 2024$1,996,041April 1, 2020September 30, 2025SUTFIN, ERIN Lreporter.nih.gov
The Epidemiology and Somatic Genomic Pathogenesis of Radon-Related StrokeNIHNational Institute of Environmental Health Sciences2023$1,995,257September 11, 2023August 31, 2026WHITSEL, ERIC A.reporter.nih.gov
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screeningNIHNational Cancer Institute2022 to 2025$1,995,233September 8, 2022August 31, 2027ROBBINS, HILARY A.reporter.nih.gov
SBIR PHASE II - TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIESNIHNational Cancer Institute2022$1,995,174September 16, 2022September 15, 2024LEVI, JELENAreporter.nih.gov
MethylScan for Early Detection of Liver and Lung CancerNIHNational Cancer Institute2022 to 2023$1,994,570June 1, 2020March 31, 2025NI, XIAOHUIreporter.nih.gov
A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIVNIHNational Cancer Institute2021 to 2024$1,992,951September 19, 2019August 31, 2025EDELMAN, E. JENNIFERreporter.nih.gov
Broad Genomic Profiling in patients with advanced lung cancer: empirically assessing adoption, clinical utility, and the value of additional evidence in an evolving landscape of cancer careNIHNational Cancer Institute2023 to 2025$1,988,877September 20, 2023August 31, 2028GROSS, CARY P.reporter.nih.gov
Drivers of histologic transformation in EGFR-mutant lung cancerNIHNational Cancer Institute2021 to 2025$1,988,000September 21, 2021August 31, 2027YU, HELENAreporter.nih.gov
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen PresentationNIHNational Cancer Institute2021 to 2023$1,979,841February 6, 2019January 31, 2025POLITI, KATERINA ABIGAILreporter.nih.gov
Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancerNIHNational Cancer Institute2023 to 2025$1,978,073July 1, 2023June 30, 2028VOKES, NATALIEreporter.nih.gov
Dissecting the role and mechanism of EML4-ALK condensates in oncogenic signaling and tumor growthNIHNational Cancer Institute2023 to 2025$1,977,128April 11, 2023March 31, 2028BIVONA, TREVER Greporter.nih.gov
Financial incentive strategies for smoking cessation in high-risk, hospitalized patients.NIHNational Institute on Drug Abuse2021 to 2023$1,976,274February 15, 2019December 31, 2024WALI, SOMAreporter.nih.gov
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancerNIHNational Cancer Institute2021 to 2024$1,968,352February 20, 2020January 31, 2026BIVONA, TREVER Greporter.nih.gov
MERTK/AXL dual inhibitors provide novel treatment for cancer by targeting tumor cells and activating anti-tumor immunityNIHNational Cancer Institute2021 to 2024$1,964,591April 1, 2020March 31, 2026WANG, XIAODONGreporter.nih.gov
The development of novel radiation-sensitizer based on ultra-small carbon dotsNIHNational Cancer Institute2021 to 2024$1,960,035July 15, 2020June 30, 2026LI, ZIBOreporter.nih.gov
ER stress-driven IRE1a-XBP1 signaling in lung cancerNIHNational Cancer Institute2023 to 2025$1,957,269February 1, 2023January 31, 2028MITTAL, VIVEKreporter.nih.gov
Contingency Management to Promote Smoking Abstinence in Cancer PatientsNIHNational Cancer Institute2021 to 2024$1,955,617July 7, 2020June 30, 2026TOLL, BENJAMIN ANDREWreporter.nih.gov
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinomaNIHNational Cancer Institute2023 to 2025$1,954,067July 10, 2023June 30, 2028LENBURG, MARC ELLIOTTreporter.nih.gov
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment InterventionsNIHNational Cancer Institute2021 to 2022$1,950,579September 8, 2020August 31, 2025MEZA, RAFAELreporter.nih.gov
Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategiesNIHNational Cancer Institute2023 to 2025$1,945,058April 10, 2023March 31, 2028ZHANG, WEIreporter.nih.gov
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalkNIHNational Cancer Institute2023 to 2025$1,942,068May 2, 2023April 30, 2028MERAD, MIRIAMreporter.nih.gov
Metabolic Mechanisms of Naphthalene Toxicity in LungNIHNational Institute of Environmental Health Sciences2021 to 2025$1,941,565August 20, 2013November 30, 2029DING, XINXINreporter.nih.gov
Therapeutic Targeting of NSD2 in Lung AdenocarcinomaNIHNational Cancer Institute2023 to 2025$1,941,343June 1, 2023May 31, 2028MAZUR, PAWEL K.reporter.nih.gov
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translationNIHNational Cancer Institute2021 to 2025$1,931,122December 7, 2020November 30, 2025GAN, BOYIreporter.nih.gov
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology ClinicsNIHNational Cancer Institute2023 to 2025$1,930,054September 21, 2023August 31, 2028REBOUSSIN, BETH A.reporter.nih.gov
Disparities in access to and outcomes of cancer surgery for rural Medicare patientsNIHNational Cancer Institute2021 to 2023$1,929,880March 1, 2020February 28, 2025TOSTESON, ANNA N. A.reporter.nih.gov
Novel therapeutics for the targeted eradication of DDR-defective tumorsNIHNational Cancer Institute2023 to 2025$1,929,781July 25, 2023June 30, 2028HERZON, SETH B.reporter.nih.gov
Targeting replication stress signaling to overcome immune evasion in small cell lung cancerNIHNational Cancer Institute2022 to 2025$1,925,939April 1, 2021March 31, 2026SEN, TRIPARNAreporter.nih.gov
Safer lung cancer radiotherapy delivery using novel artificial intelligence methodsNIHNational Cancer Institute2022 to 2025$1,925,783June 15, 2022May 31, 2027VEERARAGHAVAN, HARINIreporter.nih.gov
Novel inhibitor for oncogenic RAS for lung cancerNIHNational Cancer Institute2021 to 2025$1,922,100March 1, 2021June 30, 2026PIAZZA, GARY Areporter.nih.gov
Mechanisms of action and therapeutic targeting of the CARM1-NFIB axis in small cell lung cancerNIHNational Cancer Institute2023 to 2025$1,921,637July 1, 2023June 30, 2028MAZUR, PAWEL K.reporter.nih.gov
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposureNIHNational Cancer Institute2021 to 2024$1,921,613April 1, 2019March 31, 2026COSTA, MAXreporter.nih.gov
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized TrialNIHNational Cancer Institute2023 to 2025$1,920,677April 1, 2023March 31, 2028TAYLOR, KATHRYN Lreporter.nih.gov
Role of NSD3 in regulation of cancer pathogenesisNIHNational Cancer Institute2023 to 2025$1,917,587April 1, 2023March 31, 2028MAZUR, PAWEL K.reporter.nih.gov
Human papillomavirus in HIV associated lung cancersNIHNational Cancer Institute2021 to 2025$1,915,370April 1, 2021March 31, 2027LIN, ZHENreporter.nih.gov
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in BloodNIHNational Cancer Institute2021 to 2022$1,914,836September 6, 2018July 31, 2025PATEL, ABHIJITreporter.nih.gov
Synthetic lethality by targeting the core senescent mechanism in lung cancer.NIHNational Cancer Institute2021 to 2024$1,914,409February 1, 2020January 31, 2025WANG, XIAO-FANreporter.nih.gov
Integrating Multiple Electronic Health Records Systems to Improve Lung Cancer OutcomesNIHNational Cancer Institute2023 to 2025$1,914,078July 12, 2023June 30, 2028HAN, SUMMER Sreporter.nih.gov
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)NIHNational Cancer Institute2021 to 2023$1,911,096August 1, 2019July 31, 2026FRIEDMAN, DEBRA L.reporter.nih.gov
Ligand-mediated, vehicle-free delivery of small RNAsNIHNational Cancer Institute2021 to 2025$1,908,192April 1, 2018August 31, 2028KASINSKI, ANDREA Lreporter.nih.gov
OST Inhibition in NSCLCNIHNational Cancer Institute2021 to 2024$1,907,996June 1, 2020May 31, 2025CONTESSA, JOSEPH Nreporter.nih.gov
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIVNIHNational Cancer Institute2021 to 2024$1,907,795September 19, 2019August 31, 2025VIDRINE, DAMON J.reporter.nih.gov
Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinomaNIHNational Cancer Institute2021 to 2025$1,907,029March 1, 2021February 28, 2027KIM, JAMESreporter.nih.gov
In vivo prime editing for precision cancer mouse modelsNIHNational Cancer Institute2023 to 2025$1,892,549August 17, 2023July 31, 2028XUE, WENreporter.nih.gov
Translating phospholipase activatable fluorophores for the sensitive detection of non-small cell lung cancerNIHNational Cancer Institute2022 to 2025$1,890,521March 1, 2022February 28, 2027DELIKATNY, EDWARD Jreporter.nih.gov
Lineage heterogeneity and plasticity in lung cancerNIHNational Cancer Institute2021 to 2023$1,889,909September 20, 2019August 31, 2025WATANABE, HIDEOreporter.nih.gov
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancerNIHNational Cancer Institute2021 to 2025$1,887,371May 29, 2021December 31, 2026VINOGRADSKIY, YEVGENIYreporter.nih.gov
Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: an RCTNIHNational Institute on Drug Abuse2022 to 2024$1,887,323May 1, 2022March 31, 2028PATTEN, CHRISTI Areporter.nih.gov
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and DiseaseNIHNational Cancer Institute2021 to 2023$1,885,868September 2, 2019August 31, 2025GOLDSTEIN, ADAM Oreporter.nih.gov
Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancerNIHNational Cancer Institute2021 to 2025$1,881,297September 10, 2021August 31, 2026SCHALPER, KURT Areporter.nih.gov
SUPPLEMENTAL WORK-SARS-COV-2NIHNational Institute of Allergy and Infectious Diseases2021$1,872,652April 1, 2019July 31, 2022KAYTOR, MICHAELreporter.nih.gov
An Improved Epigenetic Algorithm for Guiding Low Dose CT Lung Cancer ScreeningNIHNational Cancer Institute2023 to 2024$1,870,731August 1, 2023July 31, 2026PHILIBERT, ROBERT Areporter.nih.gov
Characterization of YAP as a rational companion target in lung cancerNIHNational Cancer Institute2021 to 2025$1,869,970March 1, 2017December 31, 2026BIVONA, TREVER Greporter.nih.gov
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signalingNIHNational Cancer Institute2022 to 2025$1,866,603May 16, 2022April 30, 2027MENDOZA, MICHELLE CHRISTINEreporter.nih.gov
Mindfulness-based Smoking Cessation Enhanced with Mobile Technology for Low-Income SmokersNIHNational Cancer Institute2021 to 2023$1,864,511May 1, 2019April 30, 2025SPEARS, CLAIRE ADAMSreporter.nih.gov
Identifying metabolic dependencies in genetic subtypes of KRAS-driven lung cancerNIHNational Cancer Institute2021 to 2024$1,859,063March 2, 2018February 28, 2025PAPAGIANNAKOPOULOS, THALESreporter.nih.gov
Assessing the integration of tobacco cessation treatment into lung cancer screeningNIHNational Cancer Institute2021 to 2022$1,854,490April 16, 2018March 31, 2024PARK, ELYSE R.reporter.nih.gov
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genesNIHNational Cancer Institute2021 to 2024$1,853,575July 1, 2020June 30, 2025DEB, SUMITRAreporter.nih.gov
Molecular origins and impact of APOBEC3 mutagenesis in cancerNIHNational Cancer Institute2022 to 2025$1,850,023September 1, 2022August 31, 2027MACIEJOWSKI, JOHNreporter.nih.gov
Immunogenomic determinants of response and resistance to neoadjuvant anti-PD-1 in resectable NSCLCNIHNational Cancer Institute2021 to 2025$1,846,671March 1, 2021February 28, 2026SMITH, KELLIE NICOLEreporter.nih.gov
The sperm specific protein, COX6B2, promotes metabolic reprogramming in lung adenocarcinomaNIHNational Cancer Institute2021 to 2025$1,841,987September 17, 2021August 31, 2027WHITEHURST, ANGELIQUE WRIGHTreporter.nih.gov
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancerNIHNational Cancer Institute2023 to 2025$1,841,358August 1, 2023July 31, 2028LAMPE, PAUL D.reporter.nih.gov
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinomaNIHNational Cancer Institute2021 to 2022$1,840,537September 1, 2016March 31, 2024FLORES, ELSA Rreporter.nih.gov
Ultrafine Particulate Monitor for Personal Exposure AssessmentNIHNational Institute of Environmental Health Sciences2022 to 2023$1,839,486January 1, 2019June 30, 2024WOOLSEY, DAVID MICHAELreporter.nih.gov
Novel bioengineered microRNA therapeutics for lung cancerNIHNational Cancer Institute2021 to 2025$1,829,330December 1, 2018July 31, 2029YU, AIMINGreporter.nih.gov
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in CancerNIHNational Cancer Institute2021 to 2023$1,828,756April 1, 2021January 1, 2024COLLISSON, ERICreporter.nih.gov
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancerNIHNational Cancer Institute2021 to 2025$1,826,936September 1, 2021August 31, 2026SKOULIDIS, FERDINANDOSreporter.nih.gov
Chronic Exposure to House Dust Mites: A New Risk Factor for Lung Cancer in Never SmokersNIHNational Cancer Institute2023 to 2025$1,826,608June 6, 2023May 31, 2028RAZ, EYALreporter.nih.gov
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLCNIHNational Cancer Institute2022 to 2025$1,817,468July 1, 2022June 30, 2027JIN, LINGTAOreporter.nih.gov
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and CommunitiesNIHNational Cancer Institute2021 to 2024$1,811,295July 6, 2021June 30, 2027STUDTS, JAMIE Lreporter.nih.gov
Targeting alternative splicing for TCR discovery in small cell carcinomasNIHNational Cancer Institute2021 to 2022$1,809,996September 21, 2018August 31, 2024WITTE, OWEN N.reporter.nih.gov
Mucins and immune cell interactions in ovarian cancer pathogenesis & progressionNIHNational Cancer Institute2021 to 2022$1,809,110March 1, 2016February 29, 2024CRAMER, DANIEL WILLIAMreporter.nih.gov
Computational analysis of tumor ecosystems and their regulation and association with outcomesNIHNational Cancer Institute2023 to 2025$1,807,708May 1, 2023April 30, 2028GENTLES, ANDREW J.reporter.nih.gov
Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruptionNIHNational Cancer Institute2023 to 2025$1,802,817December 15, 2022November 30, 2027LAMIA, KATJA Areporter.nih.gov
A Phase 1 Trial of MLN0128 (sapanisertib) and CB-839 HCl (telaglenastat) in Advanced NSCLC PatientsNIHNational Cancer Institute2021 to 2023$1,801,566August 31, 2021July 31, 2027PAIK, PAUL Kreporter.nih.gov
Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC) on ImmunotherapyNIHNational Cancer Institute2021 to 2023$1,799,321June 4, 2021January 1, 2024KONTOS, DESPINAreporter.nih.gov
Automated Planning and Robotic Delivery of Needle Biopsies under CT Image GuidanceNIHNational Cancer Institute2023 to 2025$1,796,882June 16, 2023May 31, 2027YIP, MICHAELreporter.nih.gov
Investigation of a mitochondria-associated metastasis regulatory mechanismNIHNational Cancer Institute2021 to 2025$1,785,830September 1, 2021August 31, 2026MC NIVEN, MARK A.reporter.nih.gov
New Statistical Methods for Modelling Cancer OutcomesNIHNational Cancer Institute2021 to 2025$1,785,693January 1, 2021April 30, 2029LI, YIreporter.nih.gov
Targeting plasticity in lung cancerNIHNational Cancer Institute2023 to 2025$1,777,231January 1, 2023December 31, 2027TAMMELA, TUOMASreporter.nih.gov
Epigenetically Engineered Mouse Model for Lung Cancer TherapyNIHNational Cancer Institute2021 to 2025$1,771,128July 1, 2021June 30, 2027SHEN, LANLANreporter.nih.gov
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumorsNIHNational Cancer Institute2021 to 2024$1,762,638May 1, 2020April 30, 2026EISENMAN, ROBERT NEILreporter.nih.gov
Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung CancerNIHNational Cancer Institute2023 to 2025$1,762,407June 2, 2023May 31, 2028SCHIAVINATO EBERLIN, LIVIAreporter.nih.gov
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapyNIHNational Cancer Institute2021 to 2023$1,760,092September 8, 2021January 31, 2025NGWA, WILFREDreporter.nih.gov
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell CarcinomaNIHNational Cancer Institute2021 to 2025$1,757,751July 1, 2021June 30, 2027FIELDS, ALAN P.reporter.nih.gov
Targeting cholesterol metabolism and replication stress response in cancer therapyNIHNational Cancer Institute2021 to 2025$1,752,134February 1, 2021January 31, 2026ZHANG, JUNRANreporter.nih.gov
Histone fold Mutations in Cancer PathogenesisNIHNational Cancer Institute2022 to 2025$1,739,331August 26, 2022August 31, 2027LICHT, JONATHAN D.reporter.nih.gov
The interplay of social and molecular determinants in lung cancer disparityNIHNational Cancer Institute2022 to 2025$1,738,430July 1, 2022December 31, 2027SINGH, SHAILESHreporter.nih.gov
Multilevel Determinants of Differences in Lung Cancer Screening UtilizationNIHNational Cancer Institute2022 to 2025$1,738,430June 7, 2022April 30, 2027SAKODA, LORIreporter.nih.gov
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumorsNIHNational Cancer Institute2022 to 2025$1,735,364June 16, 2022May 31, 2027ZAROUR, HASSANE Mreporter.nih.gov
Mechanisms of BAP1 activity in human cancer developmentNIHNational Cancer Institute2021 to 2024$1,733,898December 13, 2019November 30, 2025CARBONE, MICHELEreporter.nih.gov
Identifying the Impact of SETD2 Inactivation in Lung AdenocarcinomaNIHNational Cancer Institute2022 to 2025$1,730,090December 10, 2021November 30, 2026FELDSER, DAVIDreporter.nih.gov
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after TransplantationNIHNational Cancer Institute2021 to 2023$1,728,199March 1, 2019February 29, 2024KHUSH, KIRAN KAURreporter.nih.gov
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma developmentNIHNational Cancer Institute2022 to 2025$1,727,878July 1, 2022June 30, 2027KADARA, HUMAMreporter.nih.gov
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation ReaderNIHNational Cancer Institute2022 to 2025$1,723,875January 14, 2022December 31, 2026SHI, XIAOBINGreporter.nih.gov
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5ANIHNational Cancer Institute2021 to 2023$1,722,094July 1, 2020June 30, 2024FUJIMORI, DANICA GALONICreporter.nih.gov
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the GolgiNIHNational Cancer Institute2021 to 2024$1,720,846December 1, 2019February 28, 2025KURIE, JONATHAN Mreporter.nih.gov
Neutrophil derived proteinases abolish the IFNG signature in NSCLCNIHNational Cancer Institute2023 to 2025$1,713,513July 7, 2023June 30, 2028HOUGHTON, A MCGARRYreporter.nih.gov
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancerNIHNational Cancer Institute2021 to 2024$1,712,649February 15, 2020January 31, 2025PAWELETZ, CLOUD PETERreporter.nih.gov
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancerNIHNational Cancer Institute2021 to 2024$1,710,401August 1, 2020April 30, 2026KISSIL, JOSEPHreporter.nih.gov
Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine LearningNIHNational Cancer Institute2022 to 2025$1,703,308May 23, 2022July 31, 2027DIGIROLAMO, GREGORY JAMESreporter.nih.gov
Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer TreatmentNIHNational Cancer Institute2023 to 2025$1,700,722July 25, 2023June 30, 2028MCLOUTH, LAURIEreporter.nih.gov
KRAS G12C: Kinetic and Redox Characterization of Covalent InhibitionNIHNational Cancer Institute2023 to 2025$1,692,639March 1, 2023February 29, 2028CAMPBELL, SHARON Lreporter.nih.gov
The Positively Quit Trial: Addressing disproportionate smoking rates among people living with HIVNIHNational Cancer Institute2021 to 2024$1,686,890August 1, 2019July 31, 2025MARHEFKA, STEPHANIE LYNNreporter.nih.gov
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.NIHNational Heart, Lung, and Blood Institute2021 to 2022$1,686,795July 1, 2013April 30, 2025HUNNINGHAKE, GARY MATTHEWreporter.nih.gov
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized SettingsNIHNational Cancer Institute2023 to 2025$1,685,549August 1, 2023July 31, 2028TRIPLETTE, MATTHEW ADAMreporter.nih.gov
Expanding Lung Cancer Screening to Achieve Excellence (EXHALE)NIHNational Cancer Institute2025$1,684,165September 12, 2025August 31, 2027WERNLI, KAREN Jreporter.nih.gov
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2ANIHNational Cancer Institute2021 to 2024$1,679,559April 15, 2014February 28, 2025CHEN, JINGreporter.nih.gov
Platelet Serine/Threonine Phosphatases in Cancer PathophysiologyNIHNational Cancer Institute2021 to 2025$1,674,531March 1, 2021June 30, 2026VIJAYAN, K. VINODreporter.nih.gov
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translationNIHNational Cancer Institute2021 to 2024$1,665,253July 1, 2020June 30, 2026GAN, BOYIreporter.nih.gov
Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometryNIHNational Heart, Lung, and Blood Institute2021 to 2022$1,656,289June 1, 2021May 31, 2023VINE, DAVIDreporter.nih.gov
Decoding and targeting saccharopine pathway in cancer metastasisNIHNational Cancer Institute2022 to 2025$1,649,759February 1, 2022January 31, 2027KANG, SUMINreporter.nih.gov
The Translational Regulation of Pro-apoptotic GenesNIHNational Cancer Institute2021 to 2024$1,647,330July 14, 2020June 30, 2025MILES, WAYNEreporter.nih.gov
Engineered Nanoformulation for Immune-modulation in CancerNIHNational Cancer Institute2023 to 2025$1,643,350August 15, 2023July 31, 2028RAMESH, RAJAGOPALreporter.nih.gov
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer SurgeryNIHNational Cancer Institute2021 to 2022$1,642,908September 18, 2018August 31, 2024SUN, VIRGINIA CHIH-YIreporter.nih.gov
DNA Repair Capacity Assays for Lung Disease Risk AssessmentNIHNational Cancer Institute2021 to 2022$1,638,124September 1, 2018August 31, 2024BELINSKY, STEVEN Areporter.nih.gov
Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLCNIHNational Cancer Institute2023 to 2025$1,635,382January 1, 2023August 31, 2025TRAN, PHUOC T.reporter.nih.gov
Smartphone Based Smoking Cessation Intervention for Socioeconomically Disadvantaged AdultsNIHNational Cancer Institute2021 to 2023$1,634,159February 1, 2019January 31, 2025BUSINELLE, MICHAEL S.reporter.nih.gov
In situ PEDSy and light delivery platform for Intracavitory Photodynamic TherapyNIHNational Institute of Biomedical Imaging and Bioengineering2021 to 2023$1,632,324September 20, 2020June 30, 2025ZHU, TIMOTHY C.reporter.nih.gov
Immune modulation of radiation therapy with Flt3 ligandNIHNational Cancer Institute2021$1,631,702September 1, 2015August 31, 2022KELER, TIBORreporter.nih.gov
Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase InhibitorsNIHNational Cancer Institute2021 to 2025$1,631,005February 20, 2012June 30, 2028HATA, AARON Nreporter.nih.gov
Financial incentives for homeless smokers: A community-based RCTNIHNational Cancer Institute2021 to 2024$1,630,201April 1, 2019May 31, 2025BAGGETT, TRAVIS P.reporter.nih.gov
Development of a RUVBL1/2 Inhibitor as a Radiosensitizer and Immune Stimulator for NSCLCNIHNational Cancer Institute2023 to 2025$1,626,628June 1, 2023May 31, 2028KITTLER, RALFreporter.nih.gov
Targeting the cytokine circuitry of KRAS-driven lung cancerNIHNational Cancer Institute2021 to 2024$1,625,555April 1, 2015May 31, 2026BARBIE, DAVID Areporter.nih.gov
Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancerNIHNational Cancer Institute2021 to 2023$1,623,911February 1, 2019December 31, 2024LI, RUIJIANGreporter.nih.gov
Arsenic carcinogenesis and disruption of histone variant H3.3 assemblyNIHNational Institute of Environmental Health Sciences2021 to 2023$1,623,714September 6, 2019May 31, 2025JIN, CHUNYUANreporter.nih.gov
The NYU Women's Health StudyNIHNational Cancer Institute2021 to 2023$1,621,115May 1, 2015April 30, 2025CHEN, YUreporter.nih.gov
Implementing a Scalable Smoke-free Home Intervention in Armenia and GeorgiaNIHNational Cancer Institute2023 to 2025$1,619,050February 1, 2023January 31, 2028BERG, CARLA Jreporter.nih.gov
Okazaki fragment maturation: mutagenesis and cell survivalNIHNational Cancer Institute2023 to 2025$1,616,011April 1, 2023March 31, 2028SHEN, BINGHUIreporter.nih.gov
Manipulating normal estrogen physiology as a therapeutic approach in cancerNIHNational Cancer Institute2023 to 2025$1,615,506February 7, 2023January 31, 2028MCDONNELL, DONALD Preporter.nih.gov
Strategies to predict and overcome resistance to cancer immunotherapyNIHNational Cancer Institute2023 to 2025$1,615,103March 1, 2023February 29, 2028REINER, STEVEN Lreporter.nih.gov
c-Myc modulation and its implications in EGFR-targeted cancer therapyNIHNational Cancer Institute2021 to 2025$1,613,721July 7, 2020June 30, 2026SUN, SHI-YONGreporter.nih.gov
Developing new therapeutic strategies for brain metastasisNIHNational Cancer Institute2023 to 2025$1,609,412February 1, 2023January 31, 2028HERNANDO, EVAreporter.nih.gov
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMANIHNational Cancer Institute2021 to 2023$1,608,570February 1, 2019January 31, 2025GRINSTAFF, MARK W.reporter.nih.gov
Novel Radiomics for Predicting Response to Immunotherapy for Lung CancerNIHNational Cancer Institute2022 to 2025$1,600,994April 2, 2021March 31, 2027MADABHUSHI, ANANTreporter.nih.gov
Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor MicroenvironmentsNIHNational Cancer Institute2023 to 2025$1,600,331June 1, 2023May 31, 2028TAVERNA, JOSEPHINE Areporter.nih.gov
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)NIHNational Cancer Institute2023 to 2025$1,597,454July 5, 2023June 30, 2028BRAITHWAITE, DEJANA Kreporter.nih.gov
Identifying and understanding drivers of chemoresistance in small cell lung cancerNIHNational Cancer Institute2023 to 2025$1,594,869July 1, 2023June 30, 2028MACPHERSON, DAVIDreporter.nih.gov
Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses.NIHNational Cancer Institute2024 to 2025$1,593,596April 1, 2024March 31, 2029LIEN, EVAN CHENreporter.nih.gov
Increasing Lung cancer screening Effectiveness and Access through Regional Networks (I-LEARN)NIHNational Cancer Institute2025$1,593,217September 15, 2025August 31, 2027RENDLE, KATHARINE A.reporter.nih.gov
Unmet needs for specific subsets of EGFR mutated lung cancerNIHNational Cancer Institute2021 to 2024$1,582,251February 24, 2023January 31, 2025COSTA, DANIEL BOTELHOreporter.nih.gov
Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancerNIHNational Cancer Institute2022 to 2025$1,579,999January 1, 2022December 31, 2026SCAGLIONI, PIER PAOLOreporter.nih.gov
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer ProgressionNIHNational Cancer Institute2022 to 2025$1,579,675August 5, 2022July 31, 2027FANG, JIAreporter.nih.gov
Glutaredoxin, Glutathione Metabolism and Lung CancerNIHNational Cancer Institute2023 to 2025$1,576,658May 10, 2023April 30, 2028JANSSEN-HEININGER, YVONNE M. W.reporter.nih.gov
Novel Minimally Invasive Endobronchial Approach for Lung Cancer AblationNIHNational Cancer Institute2021 to 2022$1,567,912April 1, 2019August 31, 2025LEVIN, HOWARDreporter.nih.gov
Non-genomic resistance mechanisms in EGFR-mutant lung cancerNIHNational Cancer Institute2022 to 2025$1,565,882March 1, 2009May 31, 2027HATA, AARON Nreporter.nih.gov
(8) Genetics of Immune Related Adverse Events and Response to ImmunotherapyNIHNational Cancer Institute2021 to 2023$1,564,610July 1, 2018June 30, 2024ZIV, ELADreporter.nih.gov
Role of KAT5 in lung cancerNIHNational Cancer Institute2021 to 2024$1,560,690February 7, 2020January 31, 2025KOBAYASHI, SUSUMUreporter.nih.gov
Healthcare Access Dimensions and Racial Disparities in Lung CancerNIHNational Institute on Minority Health and Health Disparities2021 to 2024$1,560,447September 2, 2021May 31, 2026LIU, YINGreporter.nih.gov
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCERNIHNational Cancer Institute2021 to 2024$1,555,447December 1, 2012November 30, 2025NGUYEN, DON Xreporter.nih.gov
Novel Methods for Identifying Genetic Interactions for Cancer PrognosisNIHNational Cancer Institute2021 to 2024$1,555,447July 1, 2016June 30, 2025MA, SHUANGGEreporter.nih.gov
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in MiceNIHNational Cancer Institute2021 to 2024$1,551,402July 1, 2020June 30, 2025HANCOCK, WAYNE WILLIAMreporter.nih.gov
Facilitating Scale-Up and Sustainment of High-Quality Lung Cancer Screening Using the QUILS SystemNIHNational Cancer Institute2025$1,549,462September 8, 2025August 31, 2027STUDTS, JAMIE Lreporter.nih.gov
Understanding determinants of racial disparities in lung cancer incidenceNIHNational Cancer Institute2021 to 2023$1,548,066May 7, 2020April 30, 2025ALDRICH, MELINDAreporter.nih.gov
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapyNIHNational Cancer Institute2022 to 2025$1,539,465March 1, 2022February 28, 2027SIEGWART, DANIEL JOHNreporter.nih.gov
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung CancerNIHNational Cancer Institute2021 to 2024$1,536,429January 1, 2018December 31, 2024GIBBONS, DON LYNNreporter.nih.gov
Nudging Provider Adoption of Clinical Decision Support: Implementation of an EHR-Agnostic Pulmonary Embolism Risk Prediction ToolNIHNational Heart, Lung, and Blood Institute2024 to 2025$1,532,859April 1, 2024March 31, 2029RICHARDSON, SAFIYAreporter.nih.gov
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesisNIHNational Cancer Institute2022 to 2025$1,531,763August 24, 2022July 31, 2027QU, ZHAOXIAreporter.nih.gov
The Epidemiology of the Weiss Cohort ProjectNIHNational Institute on Drug Abuse2021 to 2022$1,531,257August 15, 2020June 30, 2023WEISS, STANLEY Hreporter.nih.gov
Cell-of-Origin Footprints of Passenger Mutations in Human Lung CancerNIHNational Cancer Institute2023 to 2025$1,530,350July 1, 2023August 31, 2026IMIELINSKI, MARCINreporter.nih.gov
Detecting DICER1: A global partnership to cure pediatric lung cancerNIHNational Cancer Institute2021 to 2025$1,529,269February 15, 2020January 31, 2026SCHULTZ, KRIS ANN PINEKENSTEINreporter.nih.gov
Investigation of NRF2-Dependent Metabolic LiabilitiesNIHNational Cancer Institute2021 to 2024$1,529,193July 1, 2023June 30, 2025DENICOLA, GINA MARIEreporter.nih.gov
Mechanisms of Arginine Deprivation in Small Cell Lung CancerNIHNational Cancer Institute2022 to 2025$1,523,725July 1, 2022June 30, 2026OLIVER, TRUDY GALEreporter.nih.gov
Developing a novel agonist of CD137 for cancer immunopreventionNIHNational Cancer Institute2024 to 2025$1,522,188July 17, 2024May 31, 2026SHIRWAN, HAVALreporter.nih.gov
DNA damaging therapy and immune response in small cell lung cancer subtypesNIHNational Cancer Institute2022 to 2025$1,521,891July 1, 2016March 31, 2027BYERS, LAUREN AVERETTreporter.nih.gov
Targeting ABL kinases to regulate epithelial cell plasticity and regeneration following injuryNIHNational Heart, Lung, and Blood Institute2021 to 2023$1,520,108June 1, 2020April 30, 2024PENDERGAST, ANN MARIEreporter.nih.gov
Mechanisms of adaptation and resistance to emerging therapies for lung cancerNIHNational Cancer Institute2023 to 2025$1,516,847May 1, 2023April 30, 2028LITO, PIROreporter.nih.gov
Biomarker phenotypes of air pollution and cancer risk in IndiaNIHNational Institute of Environmental Health Sciences2021 to 2025$1,516,120September 23, 2021June 30, 2027STEPANOV, IRINAreporter.nih.gov
Lung Screening: Efficacy versus EffectivenessNIHNational Cancer Institute2021 to 2023$1,513,860January 1, 2018December 31, 2024GAREEN, ILANA Freporter.nih.gov
Translational regulation during cigarette smoking-induced reprogramming of the tRNA epitranscriptome, in vitro and in a mouse smoking modelNIHNational Institute of Environmental Health Sciences2021 to 2024$1,511,960June 9, 2020March 31, 2026BEGLEY, THOMAS Jreporter.nih.gov
Deciphering the Role of Reductive Stress in Non Small Cell Lung CancerNIHNational Cancer Institute2022 to 2025$1,510,300December 13, 2021November 30, 2026BAR-PELED, LIRONreporter.nih.gov
Pdcd4-Rictor Interaction in Suppression of Lung TumorigenesisNIHNational Cancer Institute2023 to 2025$1,507,195September 20, 2023August 31, 2028YANG, HSIN-SHENGreporter.nih.gov
Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumorsNIHNational Cancer Institute2023 to 2025$1,505,461April 10, 2023July 31, 2027BELLAT, VANESSAreporter.nih.gov
SurvivorCare: A digital health solution to support long-term cancer survivorship using patient navigationNIHNational Cancer Institute2021 to 2022$1,501,567September 21, 2021August 31, 2024HO, Y. XIANreporter.nih.gov
Cancer in Your Community: Strategies to Reduce Cancer and Chronic Disease in the Arkansas DeltaNIHOffice of the Director, National Institutes of Health2023 to 2024$1,499,585September 21, 2023April 7, 2025MITCHELL, TRENAreporter.nih.gov
Targeting epigenetic reader GAS41NIHNational Cancer Institute2021 to 2023$1,498,524April 1, 2020March 31, 2026CIERPICKI, TOMASZreporter.nih.gov
Screening for inhibitors of NSD3 as a treatment for lung cancerNIHNational Cancer Institute2023 to 2025$1,497,243January 1, 2023December 31, 2026GREMBECKA, JOLANTAreporter.nih.gov
Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and RetailNIHNational Cancer Institute2023 to 2025$1,484,132April 15, 2023March 31, 2027YANG, Y. TONYreporter.nih.gov
Towards a Comprehensive, Spatiotemporal Roadmap of Cancer MetastasisNIHNational Cancer Institute2024$1,480,500September 1, 2024August 31, 2027YANG, DIANreporter.nih.gov
Transcriptional Regulation of Lung Cancer IdentityNIHNational Cancer Institute2021 to 2025$1,470,369July 1, 2017December 31, 2027SNYDER, ERIC LEEreporter.nih.gov
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA ConjugatesNIHNational Cancer Institute2021 to 2024$1,464,921July 6, 2020June 30, 2025ZHANG, KEreporter.nih.gov
Indirect Genotoxicity in Metal CarcinogenesisNIHNational Institute of Environmental Health Sciences2021 to 2024$1,462,500January 15, 2020November 30, 2025ZHITKOVICH, ANATOLYreporter.nih.gov
Understanding lung cancer genomics in patients of African ancestryNIHNational Cancer Institute2024 to 2025$1,460,798July 1, 2024June 30, 2026CARROT-ZHANG, JIANreporter.nih.gov
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICSNIHNational Heart, Lung, and Blood Institute2021 to 2022$1,458,595August 1, 2014April 30, 2025BARR, R GRAHAMreporter.nih.gov
Proteomic determinants of response to checkpoint blockade in malignant pleuralmesotheliomaNIHNational Cancer Institute2021 to 2023$1,458,483January 1, 2021December 31, 2023BURT, BRYAN MICHAELreporter.nih.gov
Targeting ferroptosis in cancer therapyNIHNational Cancer Institute2023 to 2025$1,457,289March 1, 2023February 28, 2028GAN, BOYIreporter.nih.gov
Radiologist-Centered Artificial Intelligence (RCAI) for Lung Cancer Screening and DiagnosisNIHNational Cancer Institute2022 to 2024$1,454,447July 1, 2020May 31, 2026BAGCI, ULASreporter.nih.gov
Learning the visual and cognitive bases of lung nodule detectionNIHNational Cancer Institute2021 to 2025$1,454,150December 15, 2020November 30, 2026TONG, FRANKreporter.nih.gov
Targeting cell state transitions driving resistance to KRAS inhibitors in lung cancerNIHNational Cancer Institute2024 to 2025$1,453,893June 7, 2024May 31, 2029WONG, KWOK KINreporter.nih.gov
Understanding the induction of T cell dysfunction in the context of lung cancerNIHNational Cancer Institute2023 to 2025$1,442,174March 14, 2023February 29, 2028SPRANGER, STEFANIreporter.nih.gov
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancerNIHNational Cancer Institute2021 to 2024$1,437,238June 1, 2023May 31, 2025ABAZEED, MOHAMED E.reporter.nih.gov
Targeting DNA repair in KRAS mutated lung cancer by chemical screeningNIHNational Cancer Institute2021 to 2023$1,437,009July 1, 2019June 30, 2025ZHANG, YOU-WEIreporter.nih.gov
Investigating the neutrophil-sensory neuron crosstalk in lung cancerNIHNational Cancer Institute2023 to 2025$1,435,793July 1, 2023June 30, 2028JIN, CHENGCHENGreporter.nih.gov
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinomaNIHNational Cancer Institute2021 to 2023$1,434,476August 1, 2019July 31, 2025JONES, DAVID Rreporter.nih.gov
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLCNIHNational Cancer Institute2022 to 2025$1,426,737February 1, 2025January 31, 2027JIN, LINGTAOreporter.nih.gov
Mechanisms of cancer mutationsNIHNational Cancer Institute2023 to 2025$1,423,519December 1, 2022November 30, 2027PFEIFER, GERD Preporter.nih.gov
Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostateNIHNational Cancer Institute2024 to 2025$1,419,480July 2, 2024June 30, 2028BODEI, LISAreporter.nih.gov
Novel Incidental Calcium Evaluation (NICE)NIHNational Heart, Lung, and Blood Institute2024 to 2025$1,419,338July 1, 2024April 30, 2028RODRIGUEZ, FATIMAreporter.nih.gov
Late-stage development and de-risking of a novel monoclonal antibody immunotherapy for EGFR-positive solid cancersNIHNational Cancer Institute2024$1,418,424September 6, 2024August 31, 2026STERN, HOWARD Mreporter.nih.gov
Stationary Digital Tomosynthesis for Transbronchial Biopsy GuidanceNIHNational Institute of Biomedical Imaging and Bioengineering2022 to 2023$1,418,068September 15, 2019February 28, 2025LEE, YUEH Zreporter.nih.gov
Optimizing Tobacco Treatment for Smokers Seeking Lung Cancer ScreeningNIHNational Cancer Institute2021 to 2022$1,416,144August 9, 2016November 30, 2023OSTROFF, JAMIE S.reporter.nih.gov
DNA hypermethylation in lung tumorsNIHNational Cancer Institute2021 to 2023$1,411,319September 23, 2019August 31, 2025PFEIFER, GERD Preporter.nih.gov
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCENIHNational Cancer Institute2021 to 2023$1,411,019February 15, 2019January 31, 2025GRINSTAFF, MARK W.reporter.nih.gov
Combining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancerNIHNational Cancer Institute2024 to 2025$1,408,879March 1, 2024February 28, 2029WONG, KWOK KINreporter.nih.gov
The role of translation initiation factor eIF5B in lung cancer pathogenesisNIHNational Cancer Institute2023 to 2025$1,405,440July 6, 2023June 30, 2028O'DONNELL, KATHRYN ANNreporter.nih.gov
Identification of a novel targetable cancer stem cell regulator promoting cancer progression and metastasis in non-small cell lung cancerNIHNational Cancer Institute2023 to 2025$1,405,147February 9, 2023January 31, 2028LIN, HUI-KUANreporter.nih.gov
Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by pulmonary delivery of engineered Influenza A Virus (eIAV)NIHNational Cancer Institute2023 to 2024$1,399,999September 21, 2023August 31, 2026SRIVATSAN, MALLIKARJUNreporter.nih.gov
Improving risk stratification for lung cancer screening using peripheral blood leukocyte DNA methylation: an investigation in the National Lung Screening Trial (NLST)NIHNational Cancer Institute2024 to 2025$1,398,708March 1, 2024February 28, 2028MICHAUD, DOMINIQUE S.reporter.nih.gov
Deconstructing the collective invasion pack to define Myo10 functionNIHNational Cancer Institute2021 to 2024$1,395,284May 6, 2020April 30, 2026MARCUS, ADAM I.reporter.nih.gov
Rac guanine nucleotide exchange factors in lung cancerNIHNational Cancer Institute2024 to 2025$1,393,598July 31, 2024August 31, 2027KAZANIETZ, MARCELO G.reporter.nih.gov
PAF-Remodeled DREAM Complex in Cancer and RegenerationNIHNational Cancer Institute2021 to 2024$1,392,814March 9, 2015April 30, 2025PARK, JAE-ILreporter.nih.gov
Identification of genomic drivers of brain metastases in lung adenocarcinomaNIHNational Cancer Institute2021 to 2022$1,390,900May 1, 2018April 30, 2024BRASTIANOS, PRISCILLA KALIOPIreporter.nih.gov
Targeting UHRF1 in combinational immunotherapyNIHNational Cancer Institute2021 to 2023$1,390,617January 11, 2019June 30, 2024WANG, XIAO-FANreporter.nih.gov
Unraveling mechanisms of tumor suppression in lung cancerNIHNational Cancer Institute2021 to 2023$1,390,458June 1, 2019May 31, 2025WINSLOW, MONTE MEIERreporter.nih.gov
3D genome reorganization drives cancer developmentNIHNational Cancer Institute2024 to 2025$1,390,245June 1, 2024May 31, 2029MUZUMDAR, MANDAR DEEPAKreporter.nih.gov
A Fragment-Based Strategy for K-RAS Covalent InhibitorsNIHNational Cancer Institute2021 to 2023$1,388,881July 2, 2021March 1, 2024MEROUEH, SAMYreporter.nih.gov
Mechanism-based targeting of unique survival signaling in residual tumorsNIHNational Cancer Institute2022 to 2025$1,388,850March 22, 2022February 28, 2027WOOD, KRIS C.reporter.nih.gov
Role of the METTL13 Lysine Methyltransferase in Signaling and CancerNIHNational Cancer Institute2021 to 2023$1,387,609March 1, 2019February 28, 2025GOZANI, OR P.reporter.nih.gov
Computational and functional discovery of isoforms driving cancer and drug resistanceNIHNational Cancer Institute2024 to 2025$1,382,480February 14, 2024January 31, 2029BROOKS, ANGELA NORIEreporter.nih.gov
Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung CancerNIHNational Cancer Institute2021 to 2022$1,381,694June 7, 2018July 31, 2024YOU, MINGreporter.nih.gov
The benefits and harms of lung cancer screening in FloridaNIHNational Cancer Institute2021 to 2023$1,379,662January 1, 2020December 31, 2024BIAN, JIANGreporter.nih.gov
Developing bone morphogenetic receptor II inhibitors for the treatment of cancerNIHNational Cancer Institute2021 to 2022$1,375,957July 6, 2018June 30, 2024LANGENFELD, JOHNreporter.nih.gov
An integrated, multi-cohort approach for cancer health disparities and risk assessmentNIHNational Cancer Institute2023 to 2025$1,374,109September 15, 2023August 31, 2026NGUYEN, TIN Creporter.nih.gov
Social media support groups for adolescent vaping cessationNIHNational Cancer Institute2024 to 2025$1,369,690September 9, 2024August 31, 2029LING, PAMELA MAYreporter.nih.gov
Individually-tailored clinical decision support for management of indeterminate pulmonary nodulesNIHNational Cancer Institute2021 to 2023$1,367,858December 1, 2018November 30, 2025BUI, ALEXreporter.nih.gov
Mechanisms by which LSD1 Promotes Neuroendocrine Differentiation and Small Cell Lung CancerNIHNational Cancer Institute2023 to 2025$1,367,119December 6, 2022November 30, 2027OSER, MATTHEW GILBERTreporter.nih.gov
Tribally Engaged Approaches to Lung Screening (TEALS)NIHNational Cancer Institute2021 to 2024$1,366,766April 1, 2019November 30, 2024NAGYKALDI, ZSOLT Jreporter.nih.gov
Harnessing digital health and implementation science to promote uptake of depression treatment in cancer settings: iCan DepCareNIHNational Cancer Institute2024 to 2025$1,365,871September 1, 2024July 31, 2029MOISE, NATHALIEreporter.nih.gov
KanSurvive: Testing a model for improving cancer survivorship care in rural practiceNIHNational Cancer Institute2021 to 2023$1,358,381August 23, 2019July 31, 2025KLEMP, JENNIFER ROSEreporter.nih.gov
Immunogenetic determinants of cancer riskNIHNational Cancer Institute2024 to 2025$1,357,514June 1, 2024May 31, 2029SAMSTEIN, ROBERT Mreporter.nih.gov
(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granulesNIHNational Cancer Institute2021 to 2023$1,355,098July 1, 2019June 30, 2024BIVONA, TREVER Greporter.nih.gov
A Translational Randomized Clinical Trial of Varenicline Sampling to Promote Smoking Cessation and Scalable Treatment DisseminationNIHNational Cancer Institute2021 to 2024$1,349,420July 8, 2020June 30, 2025CARPENTER, MATTHEW Jreporter.nih.gov
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and ResistanceNIHNational Cancer Institute2021 to 2022$1,348,427September 19, 2018August 31, 2023ANDERSON, ALEXANDER ROBERTSON ALLANreporter.nih.gov
PROMINENT - IARCNIHNational Cancer Institute2022 to 2024$1,345,330June 22, 2022May 31, 2025BRENNAN, PAUL JOSEPHreporter.nih.gov
Targeting non-small cell lung cancer cells and the adverse tumor microenvironment with a small-molecule STAT3 inhibitorNIHNational Cancer Institute2024 to 2025$1,344,092December 19, 2023November 30, 2028TWEARDY, DAVID JOHNreporter.nih.gov
An innovative integrated computational framework using gene signatures for patient stratificationNIHNational Cancer Institute2023 to 2025$1,343,498December 8, 2022November 30, 2027CHENG, CHAOreporter.nih.gov
DNA adductome of human bladder from the tobacco exposomeNIHNational Institute of Environmental Health Sciences2021 to 2023$1,342,122April 1, 2019December 31, 2024TURESKY, ROBERT J.reporter.nih.gov
Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomasNIHNational Cancer Institute2024 to 2025$1,341,635May 1, 2024April 30, 2029VAKOC, CHRISTOPHERreporter.nih.gov
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.NIHNational Cancer Institute2021 to 2022$1,341,304July 11, 2018June 30, 2024EL-BARDEESY, NABEELreporter.nih.gov
Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapyNIHNational Cancer Institute2024 to 2025$1,340,716August 1, 2024July 31, 2029CASCONE, TINAreporter.nih.gov
Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancerNIHNational Cancer Institute2024 to 2025$1,338,153August 1, 2024July 31, 2029LIU, YANHONGreporter.nih.gov
Novel approaches to target KEAP1 mutant tumorsNIHNational Cancer Institute2024 to 2025$1,334,750April 5, 2024March 31, 2029PAPAGIANNAKOPOULOS, THALESreporter.nih.gov
Causal Machine Learning in Cancer Survival by Integrating Multiple High-Dimensional Observational StudiesNIHNational Cancer Institute2022 to 2025$1,328,580September 7, 2022August 31, 2027LI, YIreporter.nih.gov

Organizations

OrganizationPlaceNIH awardsNIH amountNSF awardsNSF amount
Dana-Farber Cancer InstBoston, MA32$103.5 million0$0
University of TX MD Anderson Can CTRHouston, TX65$84.1 million0$0
Vanderbilt University Medical CenterNashville, TN14$69.5 million0$0
New York University School of MedicineNew York, NY40$67.1 million0$0
H. Lee Moffitt Cancer CTR & Res InstTampa, FL28$56.6 million0$0
Sloan-Kettering Inst Can ResearchNew York, NY43$55.3 million0$0
Ohio State UniversityColumbus, OH23$54.9 million0$0
University of California, San FranciscoSan Francisco, CA39$53.8 million0$0
Icahn School of Medicine at Mount SinaiNew York, NY24$45.7 million0$0
Yale UniversityNew Haven, CT35$45.1 million0$0
Stanford UniversityStanford, CA35$41.3 million0$0
University of MinnesotaMinneapolis, MN19$40.7 million0$0
Massachusetts General HospitalBoston, MA31$39.8 million0$0
University of PennsylvaniaPhiladelphia, PA33$37.1 million0$0
Fred Hutchinson Cancer CenterSeattle, WA25$35.3 million0$0
University of Colorado DenverAurora, CO17$34.9 million0$0
Mayo Clinic RochesterRochester, MN4$33.3 million0$0
Ut Southwestern Medical CenterDallas, TX27$32.7 million0$0
Univ of North Carolina Chapel HillChapel Hill, NC26$32.3 million0$0
Washington UniversitySaint Louis, MO21$30.6 million0$0
University of California Los AngelesLos Angeles, CA19$29.6 million0$0
Northwestern University at ChicagoChicago, IL11$28.1 million0$0
Emory UniversityAtlanta, GA28$28 million0$0
Virginia Commonwealth UniversityRichmond, VA17$23 million0$0
Univ of Arkansas for Med ScisLittle Rock, AR1$21.9 million0$0
University of Michigan at Ann ArborAnn Arbor, MI18$21.1 million0$0
Marshall University Research CorporationHuntington, WV2$20.7 million0$0
Duke UniversityDurham, NC26$20.1 million0$0
University of FloridaGainesville, FL14$19.9 million0$0
Johns Hopkins UniversityBaltimore, MD17$19.7 million0$0
University of Oklahoma HLTH Sciences CTROklahoma City, OK14$18.9 million0$0
Weill Medical Coll of Cornell UnivNew York, NY18$18.3 million0$0
Columbia University Health SciencesNew York, NY17$15.5 million0$0
Wake Forest University Health SciencesWinston-Salem, NC16$15.2 million0$0
Kaiser Foundation Research InstituteOakland, CA9$14.7 million0$0
Baylor College of MedicineHouston, TX17$14.7 million0$0
Beckman Research Institute/city of HopeDuarte, CA9$12.8 million0$0
Medical University of South CarolinaCharleston, SC12$12.4 million0$0
University of California, San DiegoLa Jolla, CA9$12.2 million0$0
University of Illinois at ChicagoChicago, IL8$12 million0$0
Massachusetts Institute of TechnologyCambridge, MA8$11.7 million0$0
University of California at DavisDavis, CA8$11.4 million0$0
Rutgers Biomedical and Health SciencesNewark, NJ16$11.1 million0$0
University of ArizonaTucson, AZ6$11.1 million0$0
Thomas Jefferson UniversityPhiladelphia, PA10$11 million0$0
University of Pittsburgh at PittsburghPittsburgh, PA17$10.9 million0$0
Roswell Park Cancer Institute CorpBuffalo, NY9$10.9 million0$0
University of UtahSalt Lake City, UT20$10.3 million0$0
University of LouisvilleLouisville, KY11$10 million0$0
University of Southern CaliforniaLos Angeles, CA9$9.7 million0$0
University of KentuckyLexington, KY11$9.3 million0$0
Albert Einstein College of MedicineBronx, NY7$9.3 million0$0
Brigham and Women's HospitalBoston, MA11$8.8 million0$0
University of WashingtonSeattle, WA6$8.8 million0$0
Case Western Reserve UniversityCleveland, OH12$8.7 million0$0
University of Wisconsin-MadisonMadison, WI4$8.5 million0$0
Harvard University D/b/a Harvard School of Public HealthBoston, MA6$8.3 million0$0
University of Maryland BaltimoreBaltimore, MD7$8.2 million0$0
George Washington UniversityWashington, DC5$7.4 million0$0
University of Missouri-ColumbiaColumbia, MO6$7.3 million0$0
Booz Allen HamiltonMc Lean, VA1$7.2 million0$0
Univ of Massachusetts Med SCH WorcesterWorcester, MA5$7.1 million0$0
Trustees of Boston UniversityBoston, MA9$7 million0$0
Georgetown UniversityWashington, DC5$6.6 million0$0
Georgia State UniversityAtlanta, GA5$6.4 million0$0
Cleveland Clinic Lerner Com-CwruCleveland, OH5$6.2 million0$0
University of HawaiiHonolulu, HI4$6.2 million0$0
Van Andel Research InstituteGrand Rapids, MI4$6.2 million0$0
Salk Institute for Biological StudiesLa Jolla, CA2$5.9 million0$0
Fred Hutchinson Cancer Research CenterSeattle, WA14$5.7 million0$0
Indiana University IndianapolisIndianapolis, IN5$5.5 million0$0
Pennsylvania State Univ Hershey Med CTRHershey, PA5$5.3 million0$0
Dartmouth CollegeHanover, NH4$5.2 million0$0
PDX Pharmaceuticals, Inc.Portland, OR3$5.1 million0$0
University of ChicagoChicago, IL9$5 million0$0
University of Texas HLTH Science CenterSan Antonio, TX3$4.8 million0$0
Provincial Health Services AuthorityVancouver1$4.7 million0$0
Purdue UniversityWest Lafayette, IN4$4.6 million0$0
Icf, Inc., LLCFairfax, VA1$4.5 million0$0
International Agency for Res on CancerLyon3$4.5 million0$0
Hackensack University Medical CenterHackensack, NJ3$4.4 million0$0
Methodist Hospital Research InstituteHouston, TX4$4.4 million0$0
Research Inst of Fox Chase Can CTRPhiladelphia, PA5$4.4 million0$0
SUNY at BuffaloAmherst, NY4$4.4 million0$0
Brown UniversityProvidence, RI5$4.3 million0$0
SUNY at Stony BrookStony Brook, NY8$4.2 million0$0
Boston Children's HospitalBoston, MA3$4.2 million0$0
University of Kansas Medical CenterKansas City, KS2$4.2 million0$0
RBHS -Cancer Institute of New JerseyNew Brunswick, NJ5$4 million0$0
University of Nebraska Medical CenterOmaha, NE7$4 million0$0
University of VirginiaCharlottesville, VA2$4 million0$0
Celestial Oncology Inc.Santa Monica, CA1$3.9 million0$0
Columbus Community Clinical Oncology PRGColumbus, OH1$3.8 million0$0
Beth Israel Deaconess Medical CenterBoston, MA4$3.8 million0$0
Pennsylvania State Univ University ParkUniversity Park, PA3$3.7 million0$0
Mayo Clinic JacksonvilleJacksonville, FL3$3.6 million0$0
La Jolla Institute for ImmunologyLa Jolla, CA1$3.5 million0$0
Harvard Medical SchoolBoston, MA4$3.5 million0$0
Oregon State UniversityCorvallis, OR3$3.5 million0$0
University of Miami School of MedicineCoral Gables, FL4$3.4 million0$0

Funding by fiscal year

Fiscal yearNIH awardsNIH amountNSF awardsNSF amount
2025661$394,054,4550$0
2024699$384,521,0310$0
2023738$398,583,8850$0
2022736$396,469,4730$0
2021753$396,333,2180$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunityNumberAgencyListingClosesAward ceilingWhy it matches
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)PA-24-254NIHJuly 12, 2027Not listedNotice number printed on 10 awards here
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)PA-24-194NIHMay 7, 2027Not listedNotice number printed on 6 awards here
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)PA-24-182NIHMay 8, 2027Not listedNotice number printed on 3 awards here
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)PA-24-185NIHMay 7, 2027Not listedNotice number printed on 1 award here
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)PAR-27-089NIH93.393November 2, 2026Not listedSame assistance listing 93.393 as 321 awards here
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)PAR-25-095NIH93.393November 6, 2026$350,000Same assistance listing 93.393 as 321 awards here
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)PAR-25-096NIH93.393November 17, 2026$200,000Same assistance listing 93.393 as 321 awards here
NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)PAR-27-088NIH93.393November 20, 2026Not listedSame assistance listing 93.393 as 321 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)PAR-24-214NIH93.393January 7, 2027$375,000Same assistance listing 93.393 as 321 awards here
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)PAR-25-069NIH93.393January 7, 2027Not listedSame assistance listing 93.393 as 321 awards here
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)PAR-25-070NIH93.393January 7, 2027Not listedSame assistance listing 93.393 as 321 awards here
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)PAR-25-081NIH93.393January 7, 2027$499,999Same assistance listing 93.393 as 321 awards here
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)PAR-25-167NIH93.393January 7, 2027Not listedSame assistance listing 93.393 as 321 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)RFA-NS-25-023NIH93.393January 15, 2027$350,000Same assistance listing 93.393 as 321 awards here
Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)PAR-27-009NIH93.393January 25, 2027Not listedSame assistance listing 93.393 as 321 awards here
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)RFA-CA-26-010NIH93.393January 25, 2027Not listedSame assistance listing 93.393 as 321 awards here
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)RFA-CA-28-013NIH93.393February 9, 2027$700,000Same assistance listing 93.393 as 321 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)PA-27-100NIH93.393April 5, 2027Not listedSame assistance listing 93.393 as 321 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)PA-27-102NIH93.393April 5, 2027Not listedSame assistance listing 93.393 as 321 awards here
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)PAR-28-057NIH93.393May 25, 2027$500,000Same assistance listing 93.393 as 321 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.